faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A Hemophilia Joint Health Score-Based Model for the Economic Evaluation of Hemophilia A Prophylaxis Interventions.,PharmacoEconomics (Auckland),2025,10.1007/s40273-025-01484-1,https://experts.mcmaster.ca/display/publication3562694,2025-07-27T15:08:23.042716
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Developing a Two-Sided Decision Box to Facilitate Shared Decision-Making for Switching From Conventional to Pharmacokinetic-Tailored Prophylaxis in Haemophilia.,Haemophilia,2025,10.1111/hae.70072,https://experts.mcmaster.ca/display/publication3607068,2025-07-27T15:08:23.042730
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura.,Journal of Thrombosis and Haemostasis,2025,10.1016/j.jtha.2025.06.002,https://experts.mcmaster.ca/display/publication3596642,2025-07-27T15:08:23.042733
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Core GRADE 7: principles for moving from evidence to recommendations and decisions,The BMJ,2025,10.1136/bmj-2024-083867,https://experts.mcmaster.ca/display/publication3590750,2025-07-27T15:08:23.042735
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Benchmarking domain-specific pretrained language models to identify the best model for methodological rigor in clinical studies.,Journal of Biomedical Informatics,2025,10.1016/j.jbi.2025.104825,https://experts.mcmaster.ca/display/publication3570978,2025-07-27T15:08:23.042737
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Core GRADE 6: presenting the evidence in summary of findings tables.,The BMJ,2025,10.1136/bmj-2024-083866,https://experts.mcmaster.ca/display/publication3587715,2025-07-27T15:08:23.042738
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Core GRADE 5: rating certainty of evidence—assessing indirectness,The BMJ,2025,10.1136/bmj-2024-083865,https://experts.mcmaster.ca/display/publication3584132,2025-07-27T15:08:23.042740
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Rating certainty when the target threshold is the null and the point estimate is close to the null.,BMJ Evidence-Based Medicine,2025,10.1136/bmjebm-2024-113077,https://experts.mcmaster.ca/display/publication3554782,2025-07-27T15:08:23.042742
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Core GRADE 4: rating certainty of evidence—risk of bias, publication bias, and reasons for rating up certainty",The BMJ,2025,10.1136/bmj-2024-083864,https://experts.mcmaster.ca/display/publication3582028,2025-07-27T15:08:23.042743
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A.,Haemophilia,2025,10.1111/hae.70061,https://experts.mcmaster.ca/display/publication3582044,2025-07-27T15:08:23.042745
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Core GRADE 3: rating certainty of evidence—assessing inconsistency,The BMJ,2025,10.1136/bmj-2024-081905,https://experts.mcmaster.ca/display/publication3579501,2025-07-27T15:08:23.042746
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling.,Haemophilia,2025,10.1111/hae.70021,https://experts.mcmaster.ca/display/publication3558104,2025-07-27T15:08:23.042747
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,What You May Have Missed in 2024: Navigating New Medical Evidence.,ACP journal club,2025,10.7326/ANNALS-25-01164,https://experts.mcmaster.ca/display/publication3562693,2025-07-27T15:08:23.042749
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Core GRADE 2: choosing the target of certainty rating and assessing imprecision.,The BMJ,2025,10.1136/bmj-2024-081904,https://experts.mcmaster.ca/display/publication3576756,2025-07-27T15:08:23.042750
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Core GRADE 1: overview of the Core GRADE approach.,The BMJ,2025,10.1136/bmj-2024-081903,https://experts.mcmaster.ca/display/publication3574383,2025-07-27T15:08:23.042751
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Why Core GRADE is needed: introduction to a new series in The BMJ.,The BMJ,2025,10.1136/bmj-2024-081902,https://experts.mcmaster.ca/display/publication3569000,2025-07-27T15:08:23.042753
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Policies on artificial intelligence chatbots among academic publishers: a cross-sectional audit.,Research Integrity and Peer Review,2025,10.1186/s41073-025-00158-y,https://experts.mcmaster.ca/display/publication3546878,2025-07-27T15:08:23.042754
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Attitudes and perceptions of medical researchers towards the use of artificial intelligence chatbots in the scientific process: an international cross-sectional survey.,The Lancet Digital Health,2025,10.1016/S2589-7500(24)00202-4,https://experts.mcmaster.ca/display/publication3489774,2025-07-27T15:08:23.042755
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,RWD150 First Patient Enrolled in Pilot Phase of the Economics and Patient Outcomes in China in Hemophilia (EPOCH) Study,Value in Health,2024,10.1016/j.jval.2024.10.3708,https://experts.mcmaster.ca/display/publication3520196,2025-07-27T15:08:23.042757
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation,Blood,2024,10.1182/blood-2024-198579,https://experts.mcmaster.ca/display/publication3506476,2025-07-27T15:08:23.042758
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A mixed-methods survey and focus group study to understand researcher and clinician preferences for a Journal transparency Tool.,Scientific Reports,2024,10.1038/s41598-024-77790-z,https://experts.mcmaster.ca/display/publication3486229,2025-07-27T15:08:23.042760
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.,New England Journal of Medicine,2024,10.1056/NEJMoa2302982,https://experts.mcmaster.ca/display/publication3474659,2025-07-27T15:08:23.042761
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Thrombophilia testing: does practice follow guidelines?,Blood Advances,2024,10.1182/bloodadvances.2024013478,https://experts.mcmaster.ca/display/publication3474660,2025-07-27T15:08:23.042763
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Boosting efficiency in a clinical literature surveillance system with LightGBM.,PLOS Digital Health,2024,10.1371/journal.pdig.0000299,https://experts.mcmaster.ca/display/publication3472557,2025-07-27T15:08:23.042764
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The McMaster Health Information Research Unit: Over a Quarter-Century of Health Informatics Supporting Evidence-Based Medicine,Journal of Medical Internet Research,2024,10.2196/58764,https://experts.mcmaster.ca/display/publication3450481,2025-07-27T15:08:23.042766
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Kinetic Modeling for BT200 to Predict the Level of Plasma-Derived Coagulation Factor VIII in Humans,AAPS PharmSciTech,2024,10.1208/s12248-024-00952-4,https://experts.mcmaster.ca/display/publication3452076,2025-07-27T15:08:23.042768
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS‐Hemo platform,Haemophilia,2024,10.1111/hae.15027,https://experts.mcmaster.ca/display/publication3429329,2025-07-27T15:08:23.042769
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi‐country severe WAPPS‐Hemo haemophilia patients,Haemophilia,2024,10.1111/hae.15032,https://experts.mcmaster.ca/display/publication3429328,2025-07-27T15:08:23.042770
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors,Journal of Thrombosis and Haemostasis,2024,10.1016/j.jtha.2024.07.002,https://experts.mcmaster.ca/display/publication3450418,2025-07-27T15:08:23.042772
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE concept paper 8: judging the certainty of discrimination performance estimates of prognostic models in a body of validation studies,Journal of Clinical Epidemiology,2024,10.1016/j.jclinepi.2024.111344,https://experts.mcmaster.ca/display/publication3413027,2025-07-27T15:08:23.042773
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate,Journal of Thrombosis and Haemostasis,2024,10.1016/j.jtha.2024.06.015,https://experts.mcmaster.ca/display/publication3447909,2025-07-27T15:08:23.042775
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Scoping review of the recommendations and guidance for improving the quality of rare disease registries,Orphanet Journal of Rare Diseases,2024,10.1186/s13023-024-03193-y,https://experts.mcmaster.ca/display/publication3428521,2025-07-27T15:08:23.042776
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Health utilities in adults with hemophilia A: A retrospective cohort study,Haemophilia,2024,10.1111/hae.14979,https://experts.mcmaster.ca/display/publication3410784,2025-07-27T15:08:23.042777
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Protocol for the development of the Chatbot Assessment Reporting Tool (CHART) for clinical advice,BMJ Open,2024,10.1136/bmjopen-2023-081155,https://experts.mcmaster.ca/display/publication3450342,2025-07-27T15:08:23.042779
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence,ACP journal club,2024,10.7326/m24-0832,https://experts.mcmaster.ca/display/publication3414586,2025-07-27T15:08:23.042781
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Lower-dose emicizumab prophylaxis: can less be more?,Journal of Thrombosis and Haemostasis,2024,10.1016/j.jtha.2024.01.018,https://experts.mcmaster.ca/display/publication3410430,2025-07-27T15:08:23.042782
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada",Haemophilia,2024,10.1111/hae.14960,https://experts.mcmaster.ca/display/publication3401766,2025-07-27T15:08:23.042789
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists,Journal of Clinical Epidemiology,2024,10.1016/j.jclinepi.2023.111241,https://experts.mcmaster.ca/display/publication3383056,2025-07-27T15:08:23.042790
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Publisher preferences for a journal transparency tool: A modified three-round Delphi study.,F1000Prime Reports,2024,10.12688/f1000research.154408.2,https://experts.mcmaster.ca/display/publication3557719,2025-07-27T15:08:23.042792
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing,Blood Advances,2023,10.1182/bloodadvances.2023010177,https://experts.mcmaster.ca/display/publication3234482,2025-07-27T15:08:23.042793
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.102265,https://experts.mcmaster.ca/display/publication3320151,2025-07-27T15:08:23.042795
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients",Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.102264,https://experts.mcmaster.ca/display/publication3384977,2025-07-27T15:08:23.042796
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of strategies to mitigate misinformation in diverse settings and populations: a protocol for a living evidence synthesis,BMJ Open,2023,10.1136/bmjopen-2023-076672,https://experts.mcmaster.ca/display/publication3300566,2025-07-27T15:08:23.042798
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.102228,https://experts.mcmaster.ca/display/publication3307056,2025-07-27T15:08:23.042799
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,OC 06.5 Use of Emicizumab for the Treatment of Acquired Hemophilia A: A Systematic Review,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100462,https://experts.mcmaster.ca/display/publication3461835,2025-07-27T15:08:23.042800
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,OC 20.5 The WFH Gene Therapy Registry: A Collaborative Approach Towards a Global Resource for the Long-Term Follow-up of People with Hemophilia Treated with Gene Therapy,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100445,https://experts.mcmaster.ca/display/publication3461836,2025-07-27T15:08:23.042802
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,OC 24.1 Effect of the Type of F9 Mutation on the Pharmacokinetic Profile of Patients with Hemophilia B Treated with Extended Half-Life FIX Concentrates,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100443,https://experts.mcmaster.ca/display/publication3461837,2025-07-27T15:08:23.042803
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,OC 24.2 Estimated Factor VIII Activity Levels at the Time of Bleeding Events in Individuals with Hemophilia a Without Inhibitors,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100436,https://experts.mcmaster.ca/display/publication3461839,2025-07-27T15:08:23.042804
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,OC 24.4 Effect of F8 Mutations and Von Willebrand Factor on Pharmacokinetics of FVIII Concentrates in Severe Hemophilia A,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100438,https://experts.mcmaster.ca/display/publication3461838,2025-07-27T15:08:23.042806
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB0175 Impact of Reagent on the Estimation of Eloctate and Adynovate Pharmacokinetic (PK) Parameters?,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101061,https://experts.mcmaster.ca/display/publication3461834,2025-07-27T15:08:23.042807
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB0191 myGTR: A Patient Engagement Tool from the World Federation of Hemophilia Gene Therapy Registry,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101212,https://experts.mcmaster.ca/display/publication3461831,2025-07-27T15:08:23.042808
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB0644 Evaluation of the Burden of Bone Fractures in People Living with Hemophilia: A Registry-Based Case-Control Study,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101184,https://experts.mcmaster.ca/display/publication3461832,2025-07-27T15:08:23.042810
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB0661 Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Canadian Patients with Hemophilia A: Interim Results from the HEM-POWR Study,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101178,https://experts.mcmaster.ca/display/publication3461833,2025-07-27T15:08:23.042811
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB0827 WFH World Bleeding Disorders Registry Launches the First Global Data Collection on People with von Willebrand Disease,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101579,https://experts.mcmaster.ca/display/publication3461828,2025-07-27T15:08:23.042812
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB0837 Analysis of the Change in Diagnosis of von Willebrand Disease by Region and Economic Status,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101562,https://experts.mcmaster.ca/display/publication3461829,2025-07-27T15:08:23.042814
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB1392 Late Diagnosis of Two Adult Siblings with Bernard Soulier Syndrome (BSS),Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101516,https://experts.mcmaster.ca/display/publication3461830,2025-07-27T15:08:23.042815
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness,Vaccine,2023,10.1016/j.vaccine.2023.09.012,https://experts.mcmaster.ca/display/publication3291906,2025-07-27T15:08:23.042817
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review,Haemophilia,2023,10.1111/hae.14803,https://experts.mcmaster.ca/display/publication3247183,2025-07-27T15:08:23.042818
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Reported prevalence of von Willebrand disease worldwide in relation to income classification,Haemophilia,2023,10.1111/hae.14810,https://experts.mcmaster.ca/display/publication3251275,2025-07-27T15:08:23.042819
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Von Willebrand Disease: Gaining a global perspective,Haemophilia,2023,10.1111/hae.14804,https://experts.mcmaster.ca/display/publication3238619,2025-07-27T15:08:23.042820
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Deep learning to refine the identification of high-quality clinical research articles from the biomedical literature: Performance evaluation,Journal of Biomedical Informatics,2023,10.1016/j.jbi.2023.104384,https://experts.mcmaster.ca/display/publication3236692,2025-07-27T15:08:23.042822
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE guidance 36: updates to GRADE's approach to addressing inconsistency,Journal of Clinical Epidemiology,2023,10.1016/j.jclinepi.2023.03.003,https://experts.mcmaster.ca/display/publication2951096,2025-07-27T15:08:23.042823
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance,BMJ Evidence-Based Medicine,2023,10.1136/bmjebm-2022-111962,https://experts.mcmaster.ca/display/publication2184076,2025-07-27T15:08:23.042824
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A,Blood,2023,10.1182/blood.2022016571,https://experts.mcmaster.ca/display/publication2431117,2025-07-27T15:08:23.042826
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada,Haemophilia,2023,10.1111/hae.14723,https://experts.mcmaster.ca/display/publication2632548,2025-07-27T15:08:23.042827
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100106,https://experts.mcmaster.ca/display/publication3068251,2025-07-27T15:08:23.042829
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2022.100007,https://experts.mcmaster.ca/display/publication2952021,2025-07-27T15:08:23.042831
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature,Haemophilia,2023,10.1111/hae.14676,https://experts.mcmaster.ca/display/publication2440132,2025-07-27T15:08:23.042832
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Recommendations and guidelines for creating scholarly biomedical journals: A scoping review,PLoS ONE,2023,10.1371/journal.pone.0282168,https://experts.mcmaster.ca/display/publication3067556,2025-07-27T15:08:23.042833
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia,Journal of Thrombosis and Haemostasis,2022,10.1111/jth.15885,https://experts.mcmaster.ca/display/publication2430999,2025-07-27T15:08:23.042835
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal,BMJ Evidence-Based Medicine,2022,10.1136/bmjebm-2021-111866,https://experts.mcmaster.ca/display/publication2184075,2025-07-27T15:08:23.042836
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Switching from standard to extended half‐life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics",Haemophilia,2022,10.1111/hae.14649,https://experts.mcmaster.ca/display/publication2424750,2025-07-27T15:08:23.042838
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach,Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2022.07.014,https://experts.mcmaster.ca/display/publication2428181,2025-07-27T15:08:23.042839
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions,Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2022.07.015,https://experts.mcmaster.ca/display/publication2435789,2025-07-27T15:08:23.042840
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Overall prognosis of preschool autism spectrum disorder diagnoses,Cochrane Database of Systematic Reviews,2022,10.1002/14651858.cd012749.pub2,https://experts.mcmaster.ca/display/publication2441907,2025-07-27T15:08:23.042842
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A personalized limited sampling approach to better estimate terminal half‐life of FVIII concentrates,Journal of Thrombosis and Haemostasis,2022,10.1111/jth.15803,https://experts.mcmaster.ca/display/publication2294458,2025-07-27T15:08:23.042843
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map",Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2022.04.012,https://experts.mcmaster.ca/display/publication2192610,2025-07-27T15:08:23.042844
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,An evaluation of the COVID-19 recommendation map identified diverging clinical and public health guidance,Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2022.03.008,https://experts.mcmaster.ca/display/publication2188998,2025-07-27T15:08:23.042846
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors,Value in Health,2022,10.1016/j.jval.2022.04.724,https://experts.mcmaster.ca/display/publication2716673,2025-07-27T15:08:23.042848
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient‐derived endothelial colony‐forming cells,Journal of Thrombosis and Haemostasis,2022,10.1111/jth.15740,https://experts.mcmaster.ca/display/publication2188703,2025-07-27T15:08:23.042849
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature,Journal of Thrombosis and Haemostasis,2022,10.1111/jth.15723,https://experts.mcmaster.ca/display/publication2182254,2025-07-27T15:08:23.042850
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Emicizumab state‐of‐the‐art update,Haemophilia,2022,10.1111/hae.14524,https://experts.mcmaster.ca/display/publication2188827,2025-07-27T15:08:23.042852
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19,Vaccine,2022,10.1016/j.vaccine.2022.04.005,https://experts.mcmaster.ca/display/publication2188857,2025-07-27T15:08:23.042853
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia,HemaSphere,2022,10.1097/hs9.0000000000000694,https://experts.mcmaster.ca/display/publication2182322,2025-07-27T15:08:23.042855
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study",JMIR Human Factors,2022,10.2196/30797,https://experts.mcmaster.ca/display/publication2172480,2025-07-27T15:08:23.042856
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies,Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2021.11.024,https://experts.mcmaster.ca/display/publication2157243,2025-07-27T15:08:23.042857
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,New methods facilitated the process of prioritizing questions and health outcomes in guideline development,Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2021.11.031,https://experts.mcmaster.ca/display/publication2157242,2025-07-27T15:08:23.042859
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study",Research and Practice in Thrombosis and Haemostasis,2022,10.1002/rth2.12661,https://experts.mcmaster.ca/display/publication2180875,2025-07-27T15:08:23.042861
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders,European Journal of Haematology,2022,10.1111/ejh.13731,https://experts.mcmaster.ca/display/publication2158375,2025-07-27T15:08:23.042862
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature,Journal of Medical Internet Research,2022,10.2196/30791,https://experts.mcmaster.ca/display/publication2163956,2025-07-27T15:08:23.042863
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A taxonomy and framework for identifying and developing actionable statements in guidelines suggests avoiding informal recommendations,Journal of Clinical Epidemiology,2022,10.1016/j.jclinepi.2021.09.028,https://experts.mcmaster.ca/display/publication2142168,2025-07-27T15:08:23.042865
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"POSC37 Economic Cost of Treatment in Canada: A Multi-Centre, Retrospective Study",Value in Health,2022,10.1016/j.jval.2021.11.442,https://experts.mcmaster.ca/display/publication2429733,2025-07-27T15:08:23.043030
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Sexual issues in people with haemophilia: Awareness and strategies for overcoming communication barriers,Haemophilia,2022,10.1111/hae.14447,https://experts.mcmaster.ca/display/publication2146388,2025-07-27T15:08:23.043047
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Knowledge translation strategies for sharing evidence-based health information with older adults and their caregivers: findings from a persona-scenario method,BMC Geriatrics,2021,10.1186/s12877-021-02588-x,https://experts.mcmaster.ca/display/publication2149454,2025-07-27T15:08:23.043053
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation,JMIR Research Protocols,2021,10.2196/29398,https://experts.mcmaster.ca/display/publication2149453,2025-07-27T15:08:23.043061
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines,Blood Advances,2021,10.1182/bloodadvances.2020003577,https://experts.mcmaster.ca/display/publication2126643,2025-07-27T15:08:23.043065
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Evaluation of the sexual health in people living with hemophilia,Haemophilia,2021,10.1111/hae.14410,https://experts.mcmaster.ca/display/publication2129783,2025-07-27T15:08:23.043068
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines,Journal of Clinical Epidemiology,2021,10.1016/j.jclinepi.2021.04.016,https://experts.mcmaster.ca/display/publication1969571,2025-07-27T15:08:23.043071
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data,Research and Practice in Thrombosis and Haemostasis,2021,10.1002/rth2.12599,https://experts.mcmaster.ca/display/publication2146886,2025-07-27T15:08:23.043075
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B,Research and Practice in Thrombosis and Haemostasis,2021,10.1002/rth2.12601,https://experts.mcmaster.ca/display/publication2142105,2025-07-27T15:08:23.043078
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Machine Learning Approaches to Retrieve High-Quality, Clinically Relevant Evidence From the Biomedical Literature: Systematic Review",JMIR Medical Informatics,2021,10.2196/30401,https://experts.mcmaster.ca/display/publication2126644,2025-07-27T15:08:23.043081
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time,Haemophilia,2021,10.1111/hae.14364,https://experts.mcmaster.ca/display/publication1984959,2025-07-27T15:08:23.043115
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes,Haemophilia,2021,10.1111/hae.14369,https://experts.mcmaster.ca/display/publication1984960,2025-07-27T15:08:23.043124
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B,Cochrane Database of Systematic Reviews,2021,10.1002/14651858.cd014201,https://experts.mcmaster.ca/display/publication2126820,2025-07-27T15:08:23.043126
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference,Journal of Trauma and Acute Care Surgery,2021,10.1097/ta.0000000000003300,https://experts.mcmaster.ca/display/publication1970639,2025-07-27T15:08:23.043128
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database",Journal of Thrombosis and Haemostasis,2021,10.1111/jth.15395,https://experts.mcmaster.ca/display/publication1970638,2025-07-27T15:08:23.043134
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia",Haemophilia,2021,10.1111/hae.14268,https://experts.mcmaster.ca/display/publication1958635,2025-07-27T15:08:23.043137
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Comparison of single subject and population‐based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A,Haemophilia,2021,10.1111/hae.14329,https://experts.mcmaster.ca/display/publication1969089,2025-07-27T15:08:23.043138
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature (Preprint),,2021,10.2196/preprints.30791,https://experts.mcmaster.ca/display/publication2142041,2025-07-27T15:08:23.043140
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation,European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy,2021,10.1093/ehjcvp/pvaa052,https://experts.mcmaster.ca/display/publication1910784,2025-07-27T15:08:23.043142
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set,Research and Practice in Thrombosis and Haemostasis,2021,10.1002/rth2.12488,https://experts.mcmaster.ca/display/publication1963914,2025-07-27T15:08:23.043144
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study,Haemophilia,2021,10.1111/hae.14292,https://experts.mcmaster.ca/display/publication1961033,2025-07-27T15:08:23.043145
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Optimizing a literature surveillance strategy to retrieve sound overall prognosis and risk assessment model papers,Journal of the American Medical Informatics Association : JAMIA,2021,10.1093/jamia/ocaa232,https://experts.mcmaster.ca/display/publication1957420,2025-07-27T15:08:23.043147
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Derivation of a Pharmacokinetic Model to Include a Plasma-Derived, von Willebrand Factor-Containing Factor VIII (Koate®-DVI) Concentrate and its Low-Dose Use",Clinical Medicine Insights: Blood Disorders,2021,10.1177/26348535211062229,https://experts.mcmaster.ca/display/publication2152493,2025-07-27T15:08:23.043149
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"GRADE Concept Paper 1: Validating the “F.A.C.E” instrument using stakeholder perceptions of feasibility, acceptability, cost, and equity in guideline implement",Journal of Clinical Epidemiology,2021,10.1016/j.jclinepi.2020.11.018,https://experts.mcmaster.ca/display/publication1943041,2025-07-27T15:08:23.043150
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders,Haemophilia,2021,10.1111/hae.14247,https://experts.mcmaster.ca/display/publication1959646,2025-07-27T15:08:23.043152
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products,Research and Practice in Thrombosis and Haemostasis,2021,10.1002/rth2.12476,https://experts.mcmaster.ca/display/publication1961440,2025-07-27T15:08:23.043153
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database",The Lancet Respiratory Medicine,2021,10.1016/s2213-2600(20)30417-3,https://experts.mcmaster.ca/display/publication1936479,2025-07-27T15:08:23.043155
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Interventions to Influence Opioid Prescribing Practices for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis,American Journal of Preventive Medicine,2021,10.1016/j.amepre.2020.07.012,https://experts.mcmaster.ca/display/publication1939077,2025-07-27T15:08:23.043156
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Non‐severe haemophilia: Is it benign? – Insights from the PROBE study,Haemophilia,2021,10.1111/hae.14105,https://experts.mcmaster.ca/display/publication1923964,2025-07-27T15:08:23.043157
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients,Thrombosis Research,2020,10.1016/j.thromres.2020.10.024,https://experts.mcmaster.ca/display/publication1937724,2025-07-27T15:08:23.043159
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide,BMC Medical Research Methodology,2020,10.1186/s12874-020-00964-6,https://experts.mcmaster.ca/display/publication1895932,2025-07-27T15:08:23.043160
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults,BMJ Open,2020,10.1136/bmjopen-2020-040122,https://experts.mcmaster.ca/display/publication1940446,2025-07-27T15:08:23.043162
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company,Haemophilia,2020,10.1111/hae.14144,https://experts.mcmaster.ca/display/publication1936087,2025-07-27T15:08:23.043163
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH",Journal of Thrombosis and Haemostasis,2020,10.1111/jth.15023,https://experts.mcmaster.ca/display/publication1937783,2025-07-27T15:08:23.043165
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A",Annals of Hematology,2020,10.1007/s00277-020-04280-3,https://experts.mcmaster.ca/display/publication1928352,2025-07-27T15:08:23.043166
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews,Blood Advances,2020,10.1182/bloodadvances.2020002482,https://experts.mcmaster.ca/display/publication1934644,2025-07-27T15:08:23.043167
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis,The Lancet Haematology,2020,10.1016/s2352-3026(20)30293-3,https://experts.mcmaster.ca/display/publication1927366,2025-07-27T15:08:23.043169
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura,Journal of Thrombosis and Haemostasis,2020,10.1111/jth.15009,https://experts.mcmaster.ca/display/publication1926003,2025-07-27T15:08:23.043170
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura,Journal of Thrombosis and Haemostasis,2020,10.1111/jth.15006,https://experts.mcmaster.ca/display/publication1926001,2025-07-27T15:08:23.043175
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,ISTH guidelines for treatment of thrombotic thrombocytopenic purpura,Journal of Thrombosis and Haemostasis,2020,10.1111/jth.15010,https://experts.mcmaster.ca/display/publication1926002,2025-07-27T15:08:23.043177
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine,Journal of Clinical Epidemiology,2020,10.1016/j.jclinepi.2020.04.016,https://experts.mcmaster.ca/display/publication1813096,2025-07-27T15:08:23.043179
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The World Federation of Hemophilia Annual Global Survey 1999‐2018,Haemophilia,2020,10.1111/hae.14012,https://experts.mcmaster.ca/display/publication1914356,2025-07-27T15:08:23.043180
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,World Federation of Hemophilia Gene Therapy Registry,Haemophilia,2020,10.1111/hae.14015,https://experts.mcmaster.ca/display/publication1910847,2025-07-27T15:08:23.043182
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment,Blood Advances,2020,10.1182/bloodadvances.2020001937,https://experts.mcmaster.ca/display/publication1915840,2025-07-27T15:08:23.043183
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Context and Approach in Reporting Evaluations of Electronic Health Record–Based Implementation Projects,ACP journal club,2020,10.7326/m19-0874,https://experts.mcmaster.ca/display/publication1914539,2025-07-27T15:08:23.043184
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences",Blood Advances,2020,10.1182/bloodadvances.2020001768,https://experts.mcmaster.ca/display/publication1910855,2025-07-27T15:08:23.043186
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis,Blood,2020,10.1182/blood.2019003603,https://experts.mcmaster.ca/display/publication1695519,2025-07-27T15:08:23.043187
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS‐Hemo project,Haemophilia,2020,10.1111/hae.13977,https://experts.mcmaster.ca/display/publication1703986,2025-07-27T15:08:23.043189
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach,Clinical Pharmacokinetics,2020,10.1007/s40262-019-00832-7,https://experts.mcmaster.ca/display/publication1681631,2025-07-27T15:08:23.043191
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks,Journal of Clinical Epidemiology,2020,10.1016/j.jclinepi.2019.12.023,https://experts.mcmaster.ca/display/publication1688441,2025-07-27T15:08:23.043192
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prescriber adherence to guidelines for chronic noncancer pain management with opioids: Systematic review and meta-analysis.,Health Psychology,2020,10.1037/hea0000830,https://experts.mcmaster.ca/display/publication1689177,2025-07-27T15:08:23.043194
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Translating Clinical Questions by Physicians Into Searchable Queries: Analytical Survey Study,JMIR Medical Education,2020,10.2196/16777,https://experts.mcmaster.ca/display/publication1813227,2025-07-27T15:08:23.043195
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Psychological interventions for people with hemophilia,Cochrane Database of Systematic Reviews,2020,10.1002/14651858.cd010215.pub2,https://experts.mcmaster.ca/display/publication1699203,2025-07-27T15:08:23.043197
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Multicentre pharmacokinetic evaluation of rFVIII‐Fc (efmoroctocog alfa) in a real life and comparison with non‐extended half‐life FVIII concentrates,Haemophilia,2020,10.1111/hae.13946,https://experts.mcmaster.ca/display/publication1697012,2025-07-27T15:08:23.043198
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup,Clinical Pharmacokinetics,2020,10.1007/s40262-019-00809-6,https://experts.mcmaster.ca/display/publication1661992,2025-07-27T15:08:23.043200
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes,Research and Practice in Thrombosis and Haemostasis,2020,10.1002/rth2.12305,https://experts.mcmaster.ca/display/publication1696362,2025-07-27T15:08:23.043201
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest,Journal of Clinical Epidemiology,2020,10.1016/j.jclinepi.2019.08.012,https://experts.mcmaster.ca/display/publication1669971,2025-07-27T15:08:23.043202
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS‐Hemo): Patterns of blood sampling and patient characteristics among clinician users,Haemophilia,2020,10.1111/hae.13882,https://experts.mcmaster.ca/display/publication1681632,2025-07-27T15:08:23.043204
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Predictors of treatment adherence in patients with chronic disease using the Multidimensional Adherence Model: unique considerations for patients with haemophilia,The Journal of Haemophilia Practice,2020,10.17225/jhp00152,https://experts.mcmaster.ca/display/publication1973952,2025-07-27T15:08:23.043205
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The eCOVID-19 living recommendations map and gateway to contextualisation,Cochrane Database of Systematic Reviews,2020,,https://experts.mcmaster.ca/display/publication2187515,2025-07-27T15:08:23.043207
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1",Frontiers in Immunology,2020,10.3389/fimmu.2020.00620,https://experts.mcmaster.ca/display/publication1813481,2025-07-27T15:08:23.043208
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients,Thrombosis Research,2019,10.1016/j.thromres.2019.10.023,https://experts.mcmaster.ca/display/publication1678145,2025-07-27T15:08:23.043210
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Strategies for eliciting and synthesizing evidence for guidelines in rare diseases,BMC Medical Research Methodology,2019,10.1186/s12874-019-0713-0,https://experts.mcmaster.ca/display/publication1635403,2025-07-27T15:08:23.043211
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide,,2019,10.21203/rs.2.16277/v1,https://experts.mcmaster.ca/display/publication2951105,2025-07-27T15:08:23.043212
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males,ACP journal club,2019,10.7326/m19-1208,https://experts.mcmaster.ca/display/publication1666149,2025-07-27T15:08:23.043214
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients,Journal of Pharmacokinetics and Pharmacodynamics,2019,10.1007/s10928-019-09647-2,https://experts.mcmaster.ca/display/publication1655187,2025-07-27T15:08:23.043215
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Corrigendum,Research and Practice in Thrombosis and Haemostasis,2019,10.1002/rth2.12258,https://experts.mcmaster.ca/display/publication3278902,2025-07-27T15:08:23.043217
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins",Microporous and Mesoporous Materials,2019,10.1016/j.micromeso.2019.06.005,https://experts.mcmaster.ca/display/publication1659327,2025-07-27T15:08:23.043218
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.,Blood Transfusion,2019,10.2450/2019.0183-18,https://experts.mcmaster.ca/display/publication1629929,2025-07-27T15:08:23.043220
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A",Annals of Hematology,2019,10.1007/s00277-019-03747-2,https://experts.mcmaster.ca/display/publication1647169,2025-07-27T15:08:23.043221
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Home therapy for inherited bleeding disorders in South Africa: Results of a modified Delphi consensus process,SAMJ - South African Medical Journal,2019,10.7196/samj.2019.v109i9.13637,https://experts.mcmaster.ca/display/publication1666128,2025-07-27T15:08:23.043223
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,[Population pharmacokinetics of two recombinant human coagulation factor Ⅷ preparations in patients with hemophilia A].,Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,2019,10.3760/cma.j.issn.0253-2727.2019.08.009,https://experts.mcmaster.ca/display/publication1666148,2025-07-27T15:08:23.043224
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Emicizumab and thrombosis: The story so far,Journal of Thrombosis and Haemostasis,2019,10.1111/jth.14556,https://experts.mcmaster.ca/display/publication1659325,2025-07-27T15:08:23.043226
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?,Journal of Thrombosis and Haemostasis,2019,10.1111/jth.14469,https://experts.mcmaster.ca/display/publication1640175,2025-07-27T15:08:23.043227
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review,Research and Practice in Thrombosis and Haemostasis,2019,10.1002/rth2.12204,https://experts.mcmaster.ca/display/publication1652668,2025-07-27T15:08:23.043229
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods,ACP journal club,2019,10.7326/m18-3290,https://experts.mcmaster.ca/display/publication1644760,2025-07-27T15:08:23.043230
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Defining certainty of net benefit: a GRADE concept paper,BMJ Open,2019,10.1136/bmjopen-2018-027445,https://experts.mcmaster.ca/display/publication1644704,2025-07-27T15:08:23.043232
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The association between platelet transfusions and mortality in patients with critical illness,Transfusion,2019,10.1111/trf.15277,https://experts.mcmaster.ca/display/publication1635948,2025-07-27T15:08:23.043233
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,An evidence rating service provided valid correlates of the clinical importance of medical articles and journals,Journal of Clinical Epidemiology,2019,10.1016/j.jclinepi.2019.01.010,https://experts.mcmaster.ca/display/publication1626298,2025-07-27T15:08:23.043235
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study",Haemophilia,2019,10.1111/hae.13703,https://experts.mcmaster.ca/display/publication1634148,2025-07-27T15:08:23.043236
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians,ACP journal club,2019,10.7326/m18-2147,https://experts.mcmaster.ca/display/publication1637355,2025-07-27T15:08:23.043237
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Hemophilia trials in the twenty‐first century: Defining patient important outcomes,Research and Practice in Thrombosis and Haemostasis,2019,10.1002/rth2.12195,https://experts.mcmaster.ca/display/publication1639469,2025-07-27T15:08:23.043239
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study,Thrombosis and Haemostasis,2019,10.1055/s-0039-1677700,https://experts.mcmaster.ca/display/publication1626297,2025-07-27T15:08:23.043241
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Switching patients in the age of long-acting recombinant products?,Expert Review of Hematology,2019,10.1080/17474086.2018.1564032,https://experts.mcmaster.ca/display/publication1626302,2025-07-27T15:08:23.043242
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics,Clinical and Applied Thrombosis/Hemostasis,2019,10.1177/1076029619862052,https://experts.mcmaster.ca/display/publication1652661,2025-07-27T15:08:23.043244
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies,ACP journal club,2019,10.7326/m18-1376,https://experts.mcmaster.ca/display/publication1619765,2025-07-27T15:08:23.043245
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population?,Research and Practice in Thrombosis and Haemostasis,2019,10.1002/rth2.12172,https://experts.mcmaster.ca/display/publication1623217,2025-07-27T15:08:23.043247
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains",Haemophilia,2019,10.1111/hae.13649,https://experts.mcmaster.ca/display/publication1612046,2025-07-27T15:08:23.043248
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review",Systematic Reviews,2018,10.1186/s13643-018-0858-7,https://experts.mcmaster.ca/display/publication1608513,2025-07-27T15:08:23.043250
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia",Pilot and Feasibility Studies,2018,10.1186/s40814-018-0253-0,https://experts.mcmaster.ca/display/publication1505309,2025-07-27T15:08:23.043251
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A,Thrombosis Research,2018,10.1016/j.thromres.2018.08.004,https://experts.mcmaster.ca/display/publication1586628,2025-07-27T15:08:23.043253
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age‐matched controls,Haemophilia,2018,10.1111/hae.13595,https://experts.mcmaster.ca/display/publication1586461,2025-07-27T15:08:23.043258
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire",BMJ Open,2018,10.1136/bmjopen-2018-021900,https://experts.mcmaster.ca/display/publication1584362,2025-07-27T15:08:23.043259
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Core outcome set for gene therapy in haemophilia: Results of the coreHEMmultistakeholder project,Haemophilia,2018,10.1111/hae.13504,https://experts.mcmaster.ca/display/publication1534544,2025-07-27T15:08:23.043261
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Focusing in on use of pharmacokinetic profiles in routine hemophilia care,Research and Practice in Thrombosis and Haemostasis,2018,10.1002/rth2.12118,https://experts.mcmaster.ca/display/publication1572639,2025-07-27T15:08:23.043262
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Haemophilia clinical care and research needs: Assessing priorities,Haemophilia,2018,10.1111/hae.13544,https://experts.mcmaster.ca/display/publication1570430,2025-07-27T15:08:23.043264
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations,Research and Practice in Thrombosis and Haemostasis,2018,10.1002/rth2.12106,https://experts.mcmaster.ca/display/publication1580738,2025-07-27T15:08:23.043265
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH,Journal of Thrombosis and Haemostasis,2018,10.1111/jth.14153,https://experts.mcmaster.ca/display/publication1534560,2025-07-27T15:08:23.043267
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study,Journal of Medical Internet Research,2018,10.2196/10281,https://experts.mcmaster.ca/display/publication1560121,2025-07-27T15:08:23.043268
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes",Haemophilia,2018,10.1111/hae.13489,https://experts.mcmaster.ca/display/publication1553139,2025-07-27T15:08:23.043269
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Point‐of‐care ultrasonography in haemophilia care: Training and competency for muscular haematomas,Haemophilia,2018,10.1111/hae.13417,https://experts.mcmaster.ca/display/publication1505307,2025-07-27T15:08:23.043271
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,World bleeding disorders registry: The pilot study,Haemophilia,2018,10.1111/hae.13431,https://experts.mcmaster.ca/display/publication1496730,2025-07-27T15:08:23.043272
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.,ACP journal club,2018,10.7326/M17-0939,https://experts.mcmaster.ca/display/publication3461856,2025-07-27T15:08:23.043274
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism,American Journal of Medicine,2018,10.1016/j.amjmed.2017.11.042,https://experts.mcmaster.ca/display/publication1486915,2025-07-27T15:08:23.043275
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Guideline on terminology and definitions of updating clinical guidelines: The Updating Glossary,Journal of Clinical Epidemiology,2018,10.1016/j.jclinepi.2017.11.023,https://experts.mcmaster.ca/display/publication1543953,2025-07-27T15:08:23.043277
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Comorbidities in persons with haemophilia aged 60 years or more compared with age‐matched people from the general population,Haemophilia,2018,10.1111/hae.13379,https://experts.mcmaster.ca/display/publication1486888,2025-07-27T15:08:23.043278
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome,Journal of Thrombosis and Haemostasis,2018,10.1111/jth.14192,https://experts.mcmaster.ca/display/publication1560548,2025-07-27T15:08:23.043280
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"PP93 HTA Role In CoreHEM, A Multi-Stakeholder Core Outcome Set Project",International Journal of Technology Assessment in Health Care,2018,10.1017/s0266462318002386,https://experts.mcmaster.ca/display/publication3461854,2025-07-27T15:08:23.043281
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Researching what matters to improve chronic pain care in Canada: A priority-setting partnership process to support patient-oriented research,Canadian Journal of Pain,2018,10.1080/24740527.2018.1433959,https://experts.mcmaster.ca/display/publication1941109,2025-07-27T15:08:23.043283
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey,Journal of Clinical Epidemiology,2018,10.1016/j.jclinepi.2018.02.016,https://experts.mcmaster.ca/display/publication1505136,2025-07-27T15:08:23.043284
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Using pharmacokinetics to individualize hemophilia therapy,Hematology. American Society of Hematology. Education Program,2017,10.1182/asheducation-2017.1.595,https://experts.mcmaster.ca/display/publication1484351,2025-07-27T15:08:23.043286
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH,Journal of Thrombosis and Haemostasis,2017,10.1111/jth.13867,https://experts.mcmaster.ca/display/publication1478482,2025-07-27T15:08:23.043287
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,McMaster Optimal Aging Portal: an evidence-based database for geriatrics-focused health professionals,BMC Research Notes,2017,10.1186/s13104-017-2595-8,https://experts.mcmaster.ca/display/publication761870,2025-07-27T15:08:23.043289
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Systematic reviews of prognosis studies: a critical appraisal of five core clinical journals,Diagnostic and Prognostic Research,2017,10.1186/s41512-017-0008-z,https://experts.mcmaster.ca/display/publication1641332,2025-07-27T15:08:23.043290
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis,Thrombosis Research,2017,10.1016/j.thromres.2017.11.001,https://experts.mcmaster.ca/display/publication1478566,2025-07-27T15:08:23.043292
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis,Pharmaceutics,2017,10.3390/pharmaceutics9040047,https://experts.mcmaster.ca/display/publication1467895,2025-07-27T15:08:23.043293
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Discrimination and Calibration of Clinical Prediction Models,Journal of the American Medical Association (JAMA),2017,10.1001/jama.2017.12126,https://experts.mcmaster.ca/display/publication1467059,2025-07-27T15:08:23.043294
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Minimal dataset for post‐registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH,Journal of Thrombosis and Haemostasis,2017,10.1111/jth.13762,https://experts.mcmaster.ca/display/publication1314668,2025-07-27T15:08:23.043296
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Point of care ultrasound in haemophilia: Building a strong foundation for clinical implementation,Haemophilia,2017,10.1111/hae.13269,https://experts.mcmaster.ca/display/publication172697,2025-07-27T15:08:23.043297
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Overall prognosis of preschool autism spectrum disorder diagnoses,Cochrane Database of Systematic Reviews,2017,10.1002/14651858.cd012749,https://experts.mcmaster.ca/display/publication1601234,2025-07-27T15:08:23.043298
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Computer-Aided Systematic Review Screening Comes of Age,ACP journal club,2017,10.7326/m17-1295,https://experts.mcmaster.ca/display/publication172694,2025-07-27T15:08:23.043300
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis,Blood,2017,10.1111/jth.13701,https://experts.mcmaster.ca/display/publication172704,2025-07-27T15:08:23.043301
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Exploring some intersections between pharmacokinetics, factorVIIImeasurement and human morphometrics – impact of recent advances in haemophilia study design on our understanding of optimal haemophilia treatment",Haemophilia,2017,10.1111/hae.13210,https://experts.mcmaster.ca/display/publication172712,2025-07-27T15:08:23.043302
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Large scale studies assessing anti‐factorVIIIantibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more",British Journal of Haematology,2017,10.1111/bjh.14610,https://experts.mcmaster.ca/display/publication172706,2025-07-27T15:08:23.043304
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Switching to extended half‐life products in Canada – preliminary data,Haemophilia,2017,10.1111/hae.13245,https://experts.mcmaster.ca/display/publication172698,2025-07-27T15:08:23.043305
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,IDO1 activity in selected immune cells controls antibody responses,Journal of Immunology,2017,10.4049/jimmunol.198.supp.67.25,https://experts.mcmaster.ca/display/publication3461842,2025-07-27T15:08:23.043306
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factorVIIIFc fusion protein and conventional recombinant factorVIIIproducts,Haemophilia,2017,10.1111/hae.13160,https://experts.mcmaster.ca/display/publication172715,2025-07-27T15:08:23.043308
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development,Haemophilia,2017,10.1111/hae.13176,https://experts.mcmaster.ca/display/publication172717,2025-07-27T15:08:23.043309
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement,Haemophilia,2017,10.1111/hae.13215,https://experts.mcmaster.ca/display/publication172708,2025-07-27T15:08:23.043311
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,What is the role for population pharmacokinetics in hemophilia?,International Journal of Pharmacokinetics,2017,10.4155/ipk-2016-0018,https://experts.mcmaster.ca/display/publication3461858,2025-07-27T15:08:23.043312
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Oral contraceptive use is a provoking factor for venous thromboembolism,The BMJ,2017,10.1136/bmj.j2073,https://experts.mcmaster.ca/display/publication172702,2025-07-27T15:08:23.043313
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption,Journal of Medical Economics,2017,10.1080/13696998.2016.1265973,https://experts.mcmaster.ca/display/publication172729,2025-07-27T15:08:23.043315
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews,Journal of Clinical Epidemiology,2017,10.1016/j.jclinepi.2016.11.012,https://experts.mcmaster.ca/display/publication172721,2025-07-27T15:08:23.043316
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.,ACP journal club,2017,10.7326/M16-1785,https://experts.mcmaster.ca/display/publication3461859,2025-07-27T15:08:23.043317
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series,Haemophilia,2017,10.1111/hae.13167,https://experts.mcmaster.ca/display/publication172718,2025-07-27T15:08:23.043319
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians,ACP journal club,2017,10.7326/m16-1860,https://experts.mcmaster.ca/display/publication1314670,2025-07-27T15:08:23.043320
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument,International Urology and Nephrology,2017,10.1007/s11255-016-1436-3,https://experts.mcmaster.ca/display/publication172735,2025-07-27T15:08:23.043322
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The current state of adverse event reporting in hemophilia,Expert Review of Hematology,2017,10.1080/17474086.2017.1272410,https://experts.mcmaster.ca/display/publication172723,2025-07-27T15:08:23.043323
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Authors seldom report the most patient-important outcomes and absolute effect measures in systematic review abstracts,Journal of Clinical Epidemiology,2017,10.1016/j.jclinepi.2016.08.004,https://experts.mcmaster.ca/display/publication172755,2025-07-27T15:08:23.043324
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA,PLoS ONE,2017,10.1371/journal.pone.0171028,https://experts.mcmaster.ca/display/publication172713,2025-07-27T15:08:23.043326
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence,Journal of Clinical Epidemiology,2017,10.1016/j.jclinepi.2017.05.005,https://experts.mcmaster.ca/display/publication172699,2025-07-27T15:08:23.043327
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Guideline for opioid therapy and chronic noncancer pain,CANADIAN MEDICAL ASSOCIATION JOURNAL,2017,10.1503/cmaj.170363,https://experts.mcmaster.ca/display/publication61466,2025-07-27T15:08:23.043329
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"If You Build It, Who Will Come? A Description of User Characteristics and Experiences With the McMaster Optimal Aging Portal",Gerontology and Geriatric Medicine,2017,10.1177/2333721417737681,https://experts.mcmaster.ca/display/publication1478576,2025-07-27T15:08:23.043333
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data,Haemophilia,2017,10.1111/hae.13127,https://experts.mcmaster.ca/display/publication172726,2025-07-27T15:08:23.043335
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours,Thrombosis and Haemostasis,2017,10.1160/th16-09-0680,https://experts.mcmaster.ca/display/publication172722,2025-07-27T15:08:23.043336
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates,Thrombosis and Haemostasis,2017,10.1160/th16-12-0942,https://experts.mcmaster.ca/display/publication172707,2025-07-27T15:08:23.043338
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The GRADE Working Group clarifies the construct of certainty of evidence,Journal of Clinical Epidemiology,2017,10.1016/j.jclinepi.2017.05.006,https://experts.mcmaster.ca/display/publication172700,2025-07-27T15:08:23.043339
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"The demographics, treatment characteristics and quality of life of adult people with haemophilia in China – results from theHEROstudy",Haemophilia,2017,10.1111/hae.13071,https://experts.mcmaster.ca/display/publication172749,2025-07-27T15:08:23.043341
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Thrombosis in Inherited Fibrinogen Disorders,Transfusion Medicine and Hemotherapy,2017,10.1159/000452864,https://experts.mcmaster.ca/display/publication172701,2025-07-27T15:08:23.043342
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,VP57 Test-Retest Reliability Analysis Of The Patient Reported Outcomes Burdens And Experiences (PROBE) Study Questionnaire Test-Retest Reliability Analysis Of The PROBE Study Questionnaire,International Journal of Technology Assessment in Health Care,2017,10.1017/s0266462317003361,https://experts.mcmaster.ca/display/publication3461857,2025-07-27T15:08:23.043343
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Development of a Web-Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS-Hemo): Study Protocol,JMIR Research Protocols,2016,10.2196/resprot.6558,https://experts.mcmaster.ca/display/publication172725,2025-07-27T15:08:23.043345
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo),JMIR Research Protocols,2016,10.2196/resprot.6559,https://experts.mcmaster.ca/display/publication172728,2025-07-27T15:08:23.043346
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Interpreting trial sequential analysis,Transfusion,2016,10.1111/trf.13910,https://experts.mcmaster.ca/display/publication172730,2025-07-27T15:08:23.043348
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Evaluation of the utility of theISTH‐BATin haemophilia carriers: a multinational study,Haemophilia,2016,10.1111/hae.13089,https://experts.mcmaster.ca/display/publication594662,2025-07-27T15:08:23.043349
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A,Expert Opinion on Drug Metabolism and Toxicology,2016,10.1080/17425255.2016.1214711,https://experts.mcmaster.ca/display/publication172759,2025-07-27T15:08:23.043350
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis,Thrombosis and Haemostasis,2016,10.1160/th16-04-0266,https://experts.mcmaster.ca/display/publication172737,2025-07-27T15:08:23.043352
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,User Experiences of the McMaster Optimal Aging Portal’s Evidence Summaries and Blog Posts: Usability Study,JMIR Human Factors,2016,10.2196/humanfactors.6208,https://experts.mcmaster.ca/display/publication172757,2025-07-27T15:08:23.043353
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study,BMJ Open,2016,10.1136/bmjopen-2015-010983,https://experts.mcmaster.ca/display/publication172761,2025-07-27T15:08:23.043355
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH,Journal of Thrombosis and Haemostasis,2016,10.1111/jth.13382,https://experts.mcmaster.ca/display/publication172763,2025-07-27T15:08:23.043356
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Care models in the management of haemophilia: a systematic review,Haemophilia,2016,10.1111/hae.13000,https://experts.mcmaster.ca/display/publication172773,2025-07-27T15:08:23.043358
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Integrated multidisciplinary care for the management of chronic conditions in adults: an overview of reviews and an example of using indirect evidence to inform clinical practice recommendations in the field of rare diseases,Haemophilia,2016,10.1111/hae.13010,https://experts.mcmaster.ca/display/publication172771,2025-07-27T15:08:23.043359
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Methodology for the development of theNHF‐McMaster Guideline on Care Models for Haemophilia Management,Haemophilia,2016,10.1111/hae.13007,https://experts.mcmaster.ca/display/publication172777,2025-07-27T15:08:23.043360
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,NHF‐McMaster Guideline on Care Models for Haemophilia Management,Haemophilia,2016,10.1111/hae.13008,https://experts.mcmaster.ca/display/publication172779,2025-07-27T15:08:23.043362
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Understanding intravenous iron ordering practices for inpatients and outpatients at a large academic institution,Transfusion Medicine Reviews,2016,10.1016/j.tmrv.2016.05.005,https://experts.mcmaster.ca/display/publication2181222,2025-07-27T15:08:23.043363
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study",Haemophilia,2016,10.1111/hae.13009,https://experts.mcmaster.ca/display/publication172775,2025-07-27T15:08:23.043365
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The McMaster Optimal Aging Portal: Usability Evaluation of a Unique Evidence-Based Health Information Website,JMIR Human Factors,2016,10.2196/humanfactors.4800,https://experts.mcmaster.ca/display/publication172783,2025-07-27T15:08:23.043366
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Report on the International Society for Laboratory Hematology Survey on guidelines to support clinical hematology laboratory practice,International Journal of Laboratory Hematology,2016,10.1111/ijlh.12501,https://experts.mcmaster.ca/display/publication172784,2025-07-27T15:08:23.043368
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Variation of DNA Fragmentation Levels During Density Gradient Sperm Selection for Assisted Reproduction Techniques,Medicine (United States),2016,10.1097/md.0000000000003624,https://experts.mcmaster.ca/display/publication1457859,2025-07-27T15:08:23.043369
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Haemophilia in a real‐world setting: the value of clinical experience in data collection,European Journal of Haematology,2016,10.1111/ejh.12715,https://experts.mcmaster.ca/display/publication172789,2025-07-27T15:08:23.043374
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,FVIIIinhibitor development according to concentrate: data from theEUHASSregistry excluding overlap with other studies,Haemophilia,2016,10.1111/hae.12764,https://experts.mcmaster.ca/display/publication172810,2025-07-27T15:08:23.043375
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation,International Journal of Cardiology,2016,10.1016/j.ijcard.2015.11.035,https://experts.mcmaster.ca/display/publication172793,2025-07-27T15:08:23.043377
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study,Journal of Blood Medicine,2016,10.2147/jbm.s103087,https://experts.mcmaster.ca/display/publication172733,2025-07-27T15:08:23.043378
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis,PLoS ONE,2016,10.1371/journal.pone.0156891,https://experts.mcmaster.ca/display/publication172782,2025-07-27T15:08:23.043379
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Erratum to Fischer et al. “Inhibitor development in nonsevere haemophilia across Europe” (Thromb Haemost 2015; 114: 670-675),Thrombosis and Haemostasis,2016,10.1160/th16030001,https://experts.mcmaster.ca/display/publication995684,2025-07-27T15:08:23.043381
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Systematic reviews experience major limitations in reporting absolute effects,Journal of Clinical Epidemiology,2016,10.1016/j.jclinepi.2015.11.002,https://experts.mcmaster.ca/display/publication172795,2025-07-27T15:08:23.043382
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol,BMJ Open,2016,10.1136/bmjopen-2015-010569,https://experts.mcmaster.ca/display/publication172785,2025-07-27T15:08:23.043384
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Desmopressin acetate (DDAVP) for preventing and treating bleeding in people with mild or moderate haemophilia A,Cochrane Database of Systematic Reviews,2015,10.1002/14651858.cd011985,https://experts.mcmaster.ca/display/publication1747319,2025-07-27T15:08:23.043385
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors,Cochrane Database of Systematic Reviews,2015,10.1002/14651858.cd004449.pub4,https://experts.mcmaster.ca/display/publication172791,2025-07-27T15:08:23.043386
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions,BMC Blood Disorders,2015,10.1186/s12878-015-0022-8,https://experts.mcmaster.ca/display/publication172853,2025-07-27T15:08:23.043388
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A systematic review of definitions and reporting of bleeding outcome measures in haemophilia,Haemophilia,2015,10.1111/hae.12750,https://experts.mcmaster.ca/display/publication172812,2025-07-27T15:08:23.043389
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study),Haemophilia,2015,10.1111/hae.12768,https://experts.mcmaster.ca/display/publication172808,2025-07-27T15:08:23.043391
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Individualizing Factor Replacement Therapy in Severe Hemophilia,Seminars in Thrombosis and Hemostasis,2015,10.1055/s-0035-1552563,https://experts.mcmaster.ca/display/publication172806,2025-07-27T15:08:23.043392
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials,Journal of Thrombosis and Haemostasis,2015,10.1111/jth.13139,https://experts.mcmaster.ca/display/publication172803,2025-07-27T15:08:23.043394
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Point of care ultrasonography in haemophilia care: recommendations for training and competency evaluation,Haemophilia,2015,10.1111/hae.12767,https://experts.mcmaster.ca/display/publication172809,2025-07-27T15:08:23.043395
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII,Journal of Clinical Investigation,2015,10.1172/jci81859,https://experts.mcmaster.ca/display/publication172801,2025-07-27T15:08:23.043396
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Inhibitor development in haemophilia according to concentrate,Thrombosis and Haemostasis,2015,10.1160/th14-10-0826,https://experts.mcmaster.ca/display/publication172861,2025-07-27T15:08:23.043398
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A,Thrombosis and Haemostasis,2015,10.1160/th14-07-0621,https://experts.mcmaster.ca/display/publication172857,2025-07-27T15:08:23.043399
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A,Blood,2015,10.1182/blood-2014-10-608471,https://experts.mcmaster.ca/display/publication172814,2025-07-27T15:08:23.043401
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia,European Journal of Internal Medicine,2015,10.1016/j.ejim.2015.04.002,https://experts.mcmaster.ca/display/publication411179,2025-07-27T15:08:23.043402
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Cardiovascular disease prevalence and relevance in haemophilia: a scoping review,Haemophilia,2015,10.1111/hae.12596,https://experts.mcmaster.ca/display/publication172875,2025-07-27T15:08:23.043404
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data,Journal of Thrombosis and Haemostasis,2015,10.1111/jth.12871,https://experts.mcmaster.ca/display/publication172855,2025-07-27T15:08:23.043405
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients,The BMJ,2015,10.1136/bmj.h870,https://experts.mcmaster.ca/display/publication172849,2025-07-27T15:08:23.043407
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Pharmacokinetics of plasma‐derived vs. recombinantFVIIIconcentrates: a comparative study,Haemophilia,2015,10.1111/hae.12550,https://experts.mcmaster.ca/display/publication172883,2025-07-27T15:08:23.043408
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Commentary,Epidemiology,2015,10.1097/ede.0000000000000212,https://experts.mcmaster.ca/display/publication1640361,2025-07-27T15:08:23.043410
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Developing methodology for the creation of clinical practice guidelines for rare diseases: A report from RARE-Bestpractices,Rare Diseases,2015,10.1080/21675511.2015.1058463,https://experts.mcmaster.ca/display/publication1634028,2025-07-27T15:08:23.043411
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Development of haemophilic arthropathy of the ankle: results of a Delphi consensus survey on potential contributory factors,Haemophilia,2015,10.1111/hae.12500,https://experts.mcmaster.ca/display/publication172873,2025-07-27T15:08:23.043413
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor,Thrombosis and Haemostasis,2015,10.1160/th14-10-0882,https://experts.mcmaster.ca/display/publication172817,2025-07-27T15:08:23.043414
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Haemophilia Experiences, Results and Opportunities (HERO) study: treatment‐related characteristics of the population",Haemophilia,2015,10.1111/hae.12545,https://experts.mcmaster.ca/display/publication172879,2025-07-27T15:08:23.043416
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Inhibitor development in non-severe haemophilia across Europe,Thrombosis and Haemostasis,2015,10.1160/th14-12-1044,https://experts.mcmaster.ca/display/publication172805,2025-07-27T15:08:23.043417
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews: a methodological survey",BMJ Open,2015,10.1136/bmjopen-2015-009368,https://experts.mcmaster.ca/display/publication172802,2025-07-27T15:08:23.043418
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study,International Journal of Qualitative Studies on Health and Well-being,2015,10.3402/qhw.v10.28915,https://experts.mcmaster.ca/display/publication172794,2025-07-27T15:08:23.043420
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study.,International Journal of Qualitative Studies on Health and Well-being,2015,10.3402/qhw.v10.28915,https://experts.mcmaster.ca/display/publication172863,2025-07-27T15:08:23.043421
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels,Implementation Science,2015,10.1186/s13012-016-0462-y,https://experts.mcmaster.ca/display/publication172769,2025-07-27T15:08:23.043423
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Effectiveness of Computerized Decision Support Systems Linked to Electronic Health Records: A Systematic Review and Meta-Analysis,American Journal of Public Health,2014,10.2105/ajph.2014.302164,https://experts.mcmaster.ca/display/publication172881,2025-07-27T15:08:23.043424
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Increasing the quantity and quality of searching for current best evidence to answer clinical questions: protocol and intervention design of the MacPLUS FS Factorial Randomized Controlled Trials,Implementation Science,2014,10.1186/s13012-014-0125-9,https://experts.mcmaster.ca/display/publication61497,2025-07-27T15:08:23.043426
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Interventions for enhancing medication adherence,Cochrane Database of Systematic Reviews,2014,10.1002/14651858.cd000011.pub4,https://experts.mcmaster.ca/display/publication61512,2025-07-27T15:08:23.043427
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Developing a two‐sided intervention to facilitate shared decision‐making in haemophilia: decision boxes for clinicians and patient decision aids for patients,Haemophilia,2014,10.1111/hae.12495,https://experts.mcmaster.ca/display/publication172885,2025-07-27T15:08:23.043429
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly",European Journal of Internal Medicine,2014,10.1016/j.ejim.2014.09.019,https://experts.mcmaster.ca/display/publication411180,2025-07-27T15:08:23.043430
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Non-invasive ventilation in the treatment of sleep-related breathing disorders: A review and update,Revista Portuguesa de Pneumologia (English Edition),2014,10.1016/j.rppneu.2014.03.009,https://experts.mcmaster.ca/display/publication411183,2025-07-27T15:08:23.043432
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Patient data meta‐analysis of Post‐Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated withrAHF‐PFM,Haemophilia,2014,10.1111/hae.12480,https://experts.mcmaster.ca/display/publication172891,2025-07-27T15:08:23.043433
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Heart failure and chronic kidney disease in a registry of internal medicine wards,European Geriatric Medicine,2014,10.1016/j.eurger.2014.08.005,https://experts.mcmaster.ca/display/publication995630,2025-07-27T15:08:23.043435
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Multimorbidity and polypharmacy in the elderly: lessons from REPOSI,Internal and emergency medicine,2014,10.1007/s11739-014-1124-1,https://experts.mcmaster.ca/display/publication411181,2025-07-27T15:08:23.043436
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey,American Journal of Medicine,2014,10.1016/j.amjmed.2014.05.003,https://experts.mcmaster.ca/display/publication172905,2025-07-27T15:08:23.043438
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward,Haemophilia,2014,10.1111/hae.12511,https://experts.mcmaster.ca/display/publication172889,2025-07-27T15:08:23.043439
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study,European Journal of Internal Medicine,2014,10.1016/j.ejim.2014.06.027,https://experts.mcmaster.ca/display/publication411182,2025-07-27T15:08:23.043441
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Aryl hydrocarbon receptor control of a disease tolerance defence pathway,Nature,2014,10.1038/nature13323,https://experts.mcmaster.ca/display/publication172899,2025-07-27T15:08:23.043442
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa,Haemophilia,2014,10.1111/hae.12371,https://experts.mcmaster.ca/display/publication172931,2025-07-27T15:08:23.043443
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data fromCHARMS, the Canadian Hemophilia Assessment and Resource Management System",Haemophilia,2014,10.1111/hae.12477,https://experts.mcmaster.ca/display/publication172897,2025-07-27T15:08:23.043445
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Haemophilia Experiences, Results and Opportunities (HERO) Study: Influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia",Haemophilia,2014,10.1111/hae.12454,https://experts.mcmaster.ca/display/publication172907,2025-07-27T15:08:23.043447
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Evaluation of an automated method for measuring vonWillebrand factor activity in clinical samples without ristocetin,International Journal of Laboratory Hematology,2014,10.1111/ijlh.12218,https://experts.mcmaster.ca/display/publication172915,2025-07-27T15:08:23.043449
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,JointWFH‐ISTHsession: issues in clinical trial design,Haemophilia,2014,10.1111/hae.12415,https://experts.mcmaster.ca/display/publication172913,2025-07-27T15:08:23.043450
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PSY40 Indirect Comparison Of The Efficacy Of Recombinant Factor Viii Fc Fusion Protein And Other Factor Viii Products For ProphylaxisModeling The Effect Of Compliance,Value in Health,2014,10.1016/j.jval.2014.03.1345,https://experts.mcmaster.ca/display/publication3461871,2025-07-27T15:08:23.043451
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PSY41 Indirect Comparison Of The Efficacy Of Recombinant Factor Ix Fc Fusion Protein And Other Factor Ix Products For Prophylaxis: Simulating The Effect Of Compliance On Real-World Effectiveness,Value in Health,2014,10.1016/j.jval.2014.03.1346,https://experts.mcmaster.ca/display/publication3461867,2025-07-27T15:08:23.043453
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Patterns of tertiary prophylaxis inCanadian adults with severe and moderately severe haemophiliaB,Haemophilia,2014,10.1111/hae.12391,https://experts.mcmaster.ca/display/publication172927,2025-07-27T15:08:23.043454
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B,Cochrane Database of Systematic Reviews,2014,10.1002/14651858.cd010561.pub2,https://experts.mcmaster.ca/display/publication172911,2025-07-27T15:08:23.043456
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The haemophilia certification system in Canada.,Blood Transfusion,2014,10.2450/2014.0032-14s,https://experts.mcmaster.ca/display/publication172901,2025-07-27T15:08:23.043457
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Ruling out DVT using the Wells rule and a D-dimer test,The BMJ,2014,10.1136/bmj.g1637,https://experts.mcmaster.ca/display/publication172925,2025-07-27T15:08:23.043459
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity,Haemophilia,2014,10.1111/hae.12283,https://experts.mcmaster.ca/display/publication172929,2025-07-27T15:08:23.043460
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol (vol 2, 113, 2013)",Systematic Reviews,2014,10.1186/2046-4053-2-113,https://experts.mcmaster.ca/display/publication172939,2025-07-27T15:08:23.043462
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Erratum to: A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol",Systematic Reviews,2014,10.1186/2046-4053-3-76,https://experts.mcmaster.ca/display/publication411199,2025-07-27T15:08:23.043464
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics",Haemophilia,2014,10.1111/hae.12239,https://experts.mcmaster.ca/display/publication172947,2025-07-27T15:08:23.043465
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study,Systematic Reviews,2014,10.1186/2046-4053-3-137,https://experts.mcmaster.ca/display/publication172871,2025-07-27T15:08:23.043467
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis,Thrombosis and Haemostasis,2014,10.1160/th13-04-0336,https://experts.mcmaster.ca/display/publication172942,2025-07-27T15:08:23.043468
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance,Journal of Hematology and Oncology,2013,10.1186/1756-8722-6-63,https://experts.mcmaster.ca/display/publication172945,2025-07-27T15:08:23.043470
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation,European Journal of Internal Medicine,2013,10.1016/j.ejim.2013.08.697,https://experts.mcmaster.ca/display/publication172944,2025-07-27T15:08:23.043471
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Drug–drug interactions in a cohort of hospitalized elderly patients,Pharmacoepidemiology and Drug Safety,2013,10.1002/pds.3510,https://experts.mcmaster.ca/display/publication172943,2025-07-27T15:08:23.043473
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Erratum to “Small intestinal bacterial overgrowth and warfarin dose requirement variability” [Thromb. Res. 126 (1) (2010) 12–17],Thrombosis Research,2013,10.1016/j.thromres.2013.05.022,https://experts.mcmaster.ca/display/publication995768,2025-07-27T15:08:23.043474
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Inhibitor development in previously treated hemophilia A patients: a systematic review, meta‐analysis, and meta‐regression",Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12335,https://experts.mcmaster.ca/display/publication172949,2025-07-27T15:08:23.043476
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prevalence of potentially inappropriate medications in a cohort of hospitalized elderly: Results from the REPOSI study,European Geriatric Medicine,2013,10.1016/j.eurger.2013.07.018,https://experts.mcmaster.ca/display/publication3461870,2025-07-27T15:08:23.043477
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prophylaxis of venous thromboembolism in elderly patients with multimorbidity,Internal and emergency medicine,2013,10.1007/s11739-013-0944-8,https://experts.mcmaster.ca/display/publication172954,2025-07-27T15:08:23.043479
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B,Clinical Respiratory Journal,2013,10.1002/14651858.cd010561,https://experts.mcmaster.ca/display/publication1747317,2025-07-27T15:08:23.043481
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The Rodin (Research Of Determinants of INhibitor Development among PUPs with haemophilia) study: the clinical conundrum from the perspective of haemophilia treaters,Haemophilia,2013,10.1111/hae.12149,https://experts.mcmaster.ca/display/publication172956,2025-07-27T15:08:23.043486
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Factor VIII Products and Inhibitors in Severe Hemophilia A,New England Journal of Medicine,2013,10.1056/nejmc1301995,https://experts.mcmaster.ca/display/publication411185,2025-07-27T15:08:23.043488
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Factor VIII Products and Inhibitors in Severe Hemophilia A REPLY,New England Journal of Medicine,2013,,https://experts.mcmaster.ca/display/publication1508943,2025-07-27T15:08:23.043489
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Factor VIII products and inhibitors in severe hemophilia A.,New England Journal of Medicine,2013,10.1056/NEJMc1301995,https://experts.mcmaster.ca/display/publication172957,2025-07-27T15:08:23.043495
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Adverse Clinical Events and Mortality During Hospitalization and 3 Months After Discharge in Cognitively Impaired Elderly Patients,"The journals of gerontology. Series A, Biological sciences and medical sciences",2013,10.1093/gerona/gls181,https://experts.mcmaster.ca/display/publication172971,2025-07-27T15:08:23.043497
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.,Blood Transfusion,2013,10.2450/2012.0158-12,https://experts.mcmaster.ca/display/publication172959,2025-07-27T15:08:23.043498
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach,Current Treatment Options in Cardiovascular Medicine,2013,10.1007/s11936-012-0225-2,https://experts.mcmaster.ca/display/publication172962,2025-07-27T15:08:23.043499
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences,Journal of Clinical Epidemiology,2013,10.1016/j.jclinepi.2012.08.007,https://experts.mcmaster.ca/display/publication172960,2025-07-27T15:08:23.043501
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale,Drugs and Aging,2013,10.1007/s40266-012-0044-x,https://experts.mcmaster.ca/display/publication172964,2025-07-27T15:08:23.043502
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study,Internal and emergency medicine,2013,10.1007/s11739-011-0581-z,https://experts.mcmaster.ca/display/publication173027,2025-07-27T15:08:23.043504
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Comparison of Disease Clusters in Two Elderly Populations Hospitalized in 2008 and 2010,Gerontology,2013,10.1159/000346353,https://experts.mcmaster.ca/display/publication172961,2025-07-27T15:08:23.043505
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study,BioMed Research International,2013,10.1155/2013/901975,https://experts.mcmaster.ca/display/publication172941,2025-07-27T15:08:23.043507
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk factors for hospital readmission of elderly patients,European Journal of Internal Medicine,2013,10.1016/j.ejim.2012.10.005,https://experts.mcmaster.ca/display/publication172967,2025-07-27T15:08:23.043508
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends,Blood,2012,10.1182/blood.v120.21.1186.1186,https://experts.mcmaster.ca/display/publication1973978,2025-07-27T15:08:23.043510
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Uncertainties in baseline risk estimates and confidence in treatment effects,The BMJ,2012,10.1136/bmj.e7401,https://experts.mcmaster.ca/display/publication172965,2025-07-27T15:08:23.043511
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Applicability of the AGREE II Instrument in Evaluating the Development Process and Quality of Current National Academy of Clinical Biochemistry Guidelines,Clinical Chemistry,2012,10.1373/clinchem.2012.185850,https://experts.mcmaster.ca/display/publication172972,2025-07-27T15:08:23.043512
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Summarizing the theoretical foundation for hospital communication research: a scoping review of interdisciplinary literature,,2012,,https://experts.mcmaster.ca/display/publication1933902,2025-07-27T15:08:23.043514
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clotting factor concentrate switching and inhibitor development in hemophilia A,Blood,2012,10.1182/blood-2012-03-378927,https://experts.mcmaster.ca/display/publication172975,2025-07-27T15:08:23.043515
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH),Journal of Thrombosis and Haemostasis,2012,10.1111/j.1538-7836.2012.04735.x,https://experts.mcmaster.ca/display/publication172978,2025-07-27T15:08:23.043517
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Psychosocial aspects of haemophilia: a systematic review of methodologies and findings,Haemophilia,2012,10.1111/j.1365-2516.2011.02683.x,https://experts.mcmaster.ca/display/publication172991,2025-07-27T15:08:23.043518
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients,International Psychogeriatrics,2012,10.1017/s1041610211002353,https://experts.mcmaster.ca/display/publication172984,2025-07-27T15:08:23.043520
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Central nervous system bleeding in patients with rare bleeding disorders,Haemophilia,2012,10.1111/j.1365-2516.2011.02545.x,https://experts.mcmaster.ca/display/publication173025,2025-07-27T15:08:23.043521
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors,Haemophilia,2012,10.1111/j.1365-2516.2011.02611.x,https://experts.mcmaster.ca/display/publication173020,2025-07-27T15:08:23.043523
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Association between clusters of diseases and polypharmacy in hospitalized elderly patients: Results from the REPOSI study,European Journal of Internal Medicine,2011,10.1016/j.ejim.2011.08.029,https://experts.mcmaster.ca/display/publication172989,2025-07-27T15:08:23.043525
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Individual participant data meta-analyses compared with meta-analyses based on aggregate data,Trials,2011,10.1186/1745-6215-12-s1-a57,https://experts.mcmaster.ca/display/publication3461869,2025-07-27T15:08:23.043526
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study",Blood,2011,10.1182/blood.v118.21.26.26,https://experts.mcmaster.ca/display/publication3461849,2025-07-27T15:08:23.043528
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score,Blood,2011,10.1182/blood.v118.21.544.544,https://experts.mcmaster.ca/display/publication3461848,2025-07-27T15:08:23.043529
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Concentrate‐related inhibitor risk: is a difference always real?,Journal of Thrombosis and Haemostasis,2011,10.1111/j.1538-7836.2011.04480.x,https://experts.mcmaster.ca/display/publication172999,2025-07-27T15:08:23.043530
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study,American Journal of Hematology,2011,10.1002/ajh.22156,https://experts.mcmaster.ca/display/publication172995,2025-07-27T15:08:23.043532
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis,Seminars in Thrombosis and Hemostasis,2011,10.1055/s-0031-1297171,https://experts.mcmaster.ca/display/publication172982,2025-07-27T15:08:23.043533
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B,Clinical Respiratory Journal,2011,10.1002/14651858.cd003429.pub4,https://experts.mcmaster.ca/display/publication172997,2025-07-27T15:08:23.043535
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,In‐hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study,International Journal of Geriatric Psychiatry,2011,10.1002/gps.2627,https://experts.mcmaster.ca/display/publication173001,2025-07-27T15:08:23.043536
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The association between venous thromboembolism and physical inactivity in everyday life,The BMJ,2011,10.1136/bmj.d3865,https://experts.mcmaster.ca/display/publication173022,2025-07-27T15:08:23.043538
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Management of Inheritedvon Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients,Seminars in Thrombosis and Hemostasis,2011,10.1055/s-0031-1281037,https://experts.mcmaster.ca/display/publication172987,2025-07-27T15:08:23.043539
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Commentary,Annals of Internal Medicine,2011,,https://experts.mcmaster.ca/display/publication1747328,2025-07-27T15:08:23.043541
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care,ACP journal club,2011,10.7326/0003-4819-154-12-201106210-02013,https://experts.mcmaster.ca/display/publication173023,2025-07-27T15:08:23.043542
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,More about optimal choices in cardioembolism prevention,European Journal of Internal Medicine,2011,10.1016/j.ejim.2011.01.009,https://experts.mcmaster.ca/display/publication995613,2025-07-27T15:08:23.043544
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism,ACP journal club,2011,10.7326/0003-4819-154-9-201105030-00016,https://experts.mcmaster.ca/display/publication995796,2025-07-27T15:08:23.043545
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study",European Journal of Clinical Pharmacology,2011,10.1007/s00228-010-0977-0,https://experts.mcmaster.ca/display/publication173030,2025-07-27T15:08:23.043547
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly,European Journal of Internal Medicine,2011,10.1016/j.ejim.2010.11.009,https://experts.mcmaster.ca/display/publication173028,2025-07-27T15:08:23.043662
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Referat zu: Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study",Vasomed,2011,,https://experts.mcmaster.ca/display/publication1747356,2025-07-27T15:08:23.043665
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis,The BMJ,2011,10.1136/bmj.d813,https://experts.mcmaster.ca/display/publication173029,2025-07-27T15:08:23.043667
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clinical efficacy and safety of moroctocog alfa,Clinical Investigation,2011,10.4155/cli.10.27,https://experts.mcmaster.ca/display/publication3461860,2025-07-27T15:08:23.043668
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Recombinant Factor VIIa Concentrate versus Plasma-derived Concentrates for the Treatment of Acute Bleeding Episodes in Persons with Haemophilia and Inhibitors,European Oncology and Haematology,2011,10.17925/eoh.2011.07.02.140,https://experts.mcmaster.ca/display/publication3461861,2025-07-27T15:08:23.043670
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy.,Blood Transfusion,2011,10.2450/2010.0011-10,https://experts.mcmaster.ca/display/publication173033,2025-07-27T15:08:23.043836
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards,European Journal of Internal Medicine,2010,10.1016/j.ejim.2010.07.014,https://experts.mcmaster.ca/display/publication173032,2025-07-27T15:08:23.043838
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study,Blood,2010,10.1182/blood.v116.21.710.710,https://experts.mcmaster.ca/display/publication3461850,2025-07-27T15:08:23.043839
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients,Blood,2010,10.1182/blood.v116.21.238.238,https://experts.mcmaster.ca/display/publication3461853,2025-07-27T15:08:23.043841
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies],Blood,2010,10.1182/blood.v116.21.3169.3169,https://experts.mcmaster.ca/display/publication1973972,2025-07-27T15:08:23.043842
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.04022.x,https://experts.mcmaster.ca/display/publication173040,2025-07-27T15:08:23.043844
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor,JAMA Internal Medicine,2010,10.1001/archinternmed.2010.367,https://experts.mcmaster.ca/display/publication173034,2025-07-27T15:08:23.043845
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis",ACP journal club,2010,10.7326/0003-4819-153-8-201010190-02013,https://experts.mcmaster.ca/display/publication173036,2025-07-27T15:08:23.043846
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism",ACP journal club,2010,10.7326/0003-4819-153-8-201010190-00009,https://experts.mcmaster.ca/display/publication173035,2025-07-27T15:08:23.043848
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis,Current Pharmaceutical Design,2010,10.2174/138161210793563428,https://experts.mcmaster.ca/display/publication173038,2025-07-27T15:08:23.043849
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.03991.x,https://experts.mcmaster.ca/display/publication173039,2025-07-27T15:08:23.043851
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,In-Hospital Death and Adverse Clinical Events in Elderly Patients According to Disease Clustering: The REPOSI Study,Rejuvenation Research,2010,10.1089/rej.2009.1002,https://experts.mcmaster.ca/display/publication173043,2025-07-27T15:08:23.043852
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Small intestinal bacterial overgrowth and warfarin dose requirement variability,Thrombosis Research,2010,10.1016/j.thromres.2009.11.032,https://experts.mcmaster.ca/display/publication173056,2025-07-27T15:08:23.043854
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.03823.x,https://experts.mcmaster.ca/display/publication173049,2025-07-27T15:08:23.043855
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Mortality and causes of death in Italian persons with haemophilia, 1990–2007",Haemophilia,2010,10.1111/j.1365-2516.2009.02188.x,https://experts.mcmaster.ca/display/publication173052,2025-07-27T15:08:23.043857
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children,Circulation,2010,10.1161/circulationaha.109.913673,https://experts.mcmaster.ca/display/publication173048,2025-07-27T15:08:23.043858
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Influenza Vaccination and Vitamin K Antagonist Treatment,JAMA Internal Medicine,2010,10.1001/archinternmed.2010.49,https://experts.mcmaster.ca/display/publication173047,2025-07-27T15:08:23.043860
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Selective outcome reporting: telling and detecting true lies. The state of the science,Internal and emergency medicine,2010,10.1007/s11739-010-0371-z,https://experts.mcmaster.ca/display/publication173050,2025-07-27T15:08:23.043861
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study",European Journal of Vascular and Endovascular Surgery,2010,10.1016/j.ejvs.2009.11.022,https://experts.mcmaster.ca/display/publication173057,2025-07-27T15:08:23.043862
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus,Cochrane Database of Systematic Reviews,2010,10.1002/14651858.cd004888.pub2,https://experts.mcmaster.ca/display/publication173053,2025-07-27T15:08:23.043864
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Bone mineral density in haemophilia patients,Thrombosis and Haemostasis,2010,10.1160/th09-09-0629,https://experts.mcmaster.ca/display/publication173055,2025-07-27T15:08:23.043865
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Response: Comparing joint arthroplasties in severe hemophilia A with severe hemophilia B,Blood,2009,10.1182/blood-2009-09-244566,https://experts.mcmaster.ca/display/publication995836,2025-07-27T15:08:23.043867
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impact of Thrombophilia On Arterial Ischemic Stroke or Cerebral Venous Sinus Thromboses in Children: A Systematic Review & Meta-Analysis of Observational Studies.,Blood,2009,10.1182/blood.v114.22.3993.3993,https://experts.mcmaster.ca/display/publication1973969,2025-07-27T15:08:23.043868
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.,Blood,2009,10.1182/blood.v114.22.3494.3494,https://experts.mcmaster.ca/display/publication3461851,2025-07-27T15:08:23.043870
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature.,Blood,2009,10.1182/blood.v114.22.3154.3154,https://experts.mcmaster.ca/display/publication3461852,2025-07-27T15:08:23.043871
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET),Thrombosis Research,2009,10.1016/j.thromres.2009.05.014,https://experts.mcmaster.ca/display/publication173063,2025-07-27T15:08:23.043873
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus,American Journal of Gastroenterology,2009,10.1038/ajg.2009.311,https://experts.mcmaster.ca/display/publication173064,2025-07-27T15:08:23.043875
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment",American Journal of Hematology,2009,10.1002/ajh.21469,https://experts.mcmaster.ca/display/publication173061,2025-07-27T15:08:23.043876
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders,Blood,2009,10.1182/blood-2009-01-195313,https://experts.mcmaster.ca/display/publication173069,2025-07-27T15:08:23.043878
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends?,Haemophilia,2009,10.1111/j.1365-2516.2009.02031.x,https://experts.mcmaster.ca/display/publication173066,2025-07-27T15:08:23.043879
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy,Journal of Thrombosis and Haemostasis,2009,10.1111/j.1538-7836.2009.03318.x,https://experts.mcmaster.ca/display/publication1747358,2025-07-27T15:08:23.043881
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Performance of recalibrated ReFacto®laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one‐stage assays after infusion of recalibrated ReFacto®(B‐domain deleted recombinant factor VIII),Haemophilia,2009,10.1111/j.1365-2516.2009.01983.x,https://experts.mcmaster.ca/display/publication173071,2025-07-27T15:08:23.043883
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Errata,Haemophilia,2009,10.1111/j.1365-2516.2009.02014_3.x,https://experts.mcmaster.ca/display/publication1747359,2025-07-27T15:08:23.043884
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis (vol 14, pg 444, 2008)",Haemophilia,2009,,https://experts.mcmaster.ca/display/publication995840,2025-07-27T15:08:23.043886
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study",Haemophilia,2009,10.1111/j.1365-2516.2008.01926.x,https://experts.mcmaster.ca/display/publication411187,2025-07-27T15:08:23.043887
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature,Blood,2008,10.1182/blood.v112.11.3029.3029,https://experts.mcmaster.ca/display/publication3461846,2025-07-27T15:08:23.043889
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase.,Blood Transfusion,2008,10.2450/2008.0042-07,https://experts.mcmaster.ca/display/publication173072,2025-07-27T15:08:23.043890
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Selecting references that match constructs: the difficult job of citing the parachute hyperbole,Internal and emergency medicine,2008,10.1007/s11739-008-0149-8,https://experts.mcmaster.ca/display/publication173087,2025-07-27T15:08:23.043897
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis",Haemophilia,2008,10.1111/j.1365-2516.2008.01679.x,https://experts.mcmaster.ca/display/publication173093,2025-07-27T15:08:23.043899
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Interventions for enhancing medication adherence,Cochrane Database of Systematic Reviews,2008,10.1002/14651858.cd000011.pub3,https://experts.mcmaster.ca/display/publication175104,2025-07-27T15:08:23.043900
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Iatrogenic causes of an ICH,European Journal of Anaesthesiology,2008,10.1017/s0265021507003171,https://experts.mcmaster.ca/display/publication173089,2025-07-27T15:08:23.043902
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting,Thrombosis and Haemostasis,2008,10.1160/th07-06-0409,https://experts.mcmaster.ca/display/publication173097,2025-07-27T15:08:23.043903
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,The good use of plasma. A critical analysis of five international guidelines.,Blood Transfusion,2008,10.2450/2008.0041-07,https://experts.mcmaster.ca/display/publication173077,2025-07-27T15:08:23.043905
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence",Internal and emergency medicine,2007,10.1007/s11739-007-0058-2,https://experts.mcmaster.ca/display/publication173103,2025-07-27T15:08:23.043906
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS",Journal of Thrombosis and Haemostasis,2007,10.1111/j.1538-7836.2007.tb01920.x,https://experts.mcmaster.ca/display/publication3461862,2025-07-27T15:08:23.043907
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Chronic Prostatitis,New England Journal of Medicine,2007,10.1056/nejmc063135,https://experts.mcmaster.ca/display/publication411191,2025-07-27T15:08:23.043909
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients,Thrombosis and Haemostasis,2007,10.1160/th07-03-0201,https://experts.mcmaster.ca/display/publication173107,2025-07-27T15:08:23.043910
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Thrombophilia and Cerebral Vein Thrombosis,Frontiers of Neurology and Neuroscience,2007,10.1159/000111261,https://experts.mcmaster.ca/display/publication173101,2025-07-27T15:08:23.043912
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Influenza vaccination in patients on long-term anticoagulant therapy,Vaccine,2006,10.1016/j.vaccine.2006.05.036,https://experts.mcmaster.ca/display/publication173128,2025-07-27T15:08:23.043913
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,d-Dimer Testing to Determine the Duration of Anticoagulation Therapy,New England Journal of Medicine,2006,10.1056/nejmoa054444,https://experts.mcmaster.ca/display/publication173119,2025-07-27T15:08:23.043914
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Are placebo‐controlled trials ethical in areas where current guidelines recommend therapy? No,Journal of Thrombosis and Haemostasis,2006,10.1111/j.1538-7836.2006.02133.x,https://experts.mcmaster.ca/display/publication173125,2025-07-27T15:08:23.043916
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C.,Haematologica,2006,,https://experts.mcmaster.ca/display/publication1688439,2025-07-27T15:08:23.043917
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B,Clinical Respiratory Journal,2006,10.1002/14651858.cd003429.pub3,https://experts.mcmaster.ca/display/publication173131,2025-07-27T15:08:23.043919
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Can evidence harm? Certainly not hemophilia treatment and community,Journal of Thrombosis and Haemostasis,2006,10.1111/j.1538-7836.2006.01853.x,https://experts.mcmaster.ca/display/publication173132,2025-07-27T15:08:23.043920
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma‐derived solvent‐detergent factor VIII concentrate,Haemophilia,2006,10.1111/j.1365-2516.2006.01201.x,https://experts.mcmaster.ca/display/publication411193,2025-07-27T15:08:23.043922
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments,Cerebrovascular Diseases,2006,10.1159/000094604,https://experts.mcmaster.ca/display/publication173127,2025-07-27T15:08:23.043923
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.,Blood,2005,10.1182/blood.v106.11.3219.3219,https://experts.mcmaster.ca/display/publication3461845,2025-07-27T15:08:23.043924
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Differences between patients’, physicians’ and pharmacists’ preferences for treatment products in haemophilia: a discrete choice experiment",Haemophilia,2005,10.1111/j.1365-2516.2005.01159.x,https://experts.mcmaster.ca/display/publication411195,2025-07-27T15:08:23.043926
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Performance Comparison of Three Assay Methods Used in Fasting and Postmethionine Load Plasma Homocysteine Determinations From Patients With Vascular Disease,American Journal of Clinical Pathology,2005,10.1309/0f85mtu8kl3d7jjp,https://experts.mcmaster.ca/display/publication173137,2025-07-27T15:08:23.043927
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease,American Journal of Clinical Pathology,2005,10.1309/0F85MTU8KI.3D7.JJP,https://experts.mcmaster.ca/display/publication995646,2025-07-27T15:08:23.043928
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism,Current Pharmaceutical Design,2005,10.2174/138161205774580534,https://experts.mcmaster.ca/display/publication173135,2025-07-27T15:08:23.043930
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves,International Journal of Laboratory Hematology,2005,10.1111/j.1365-2257.2005.00713.x,https://experts.mcmaster.ca/display/publication173141,2025-07-27T15:08:23.043931
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B,Cochrane Database of Systematic Reviews,2005,10.1002/14651858.cd003429.pub2,https://experts.mcmaster.ca/display/publication173143,2025-07-27T15:08:23.043932
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Interventions to enhance medication adherence,Cochrane Database of Systematic Reviews,2005,10.1002/14651858.CD000011.pub2,https://experts.mcmaster.ca/display/publication1161503,2025-07-27T15:08:23.043934
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Corrigenda,Journal of Thrombosis and Haemostasis,2004,10.1111/j.1538-7836.2004.00945.x,https://experts.mcmaster.ca/display/publication1747345,2025-07-27T15:08:23.043935
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents (vol 2, pg 1055, 2004)",Journal of Thrombosis and Haemostasis,2004,,https://experts.mcmaster.ca/display/publication995722,2025-07-27T15:08:23.043936
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents,Journal of Thrombosis and Haemostasis,2004,10.1111/j.1538-7836.2004.00753.x,https://experts.mcmaster.ca/display/publication173234,2025-07-27T15:08:23.043938
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis,Arthritis and Rheumatism,2004,10.1002/art.20237,https://experts.mcmaster.ca/display/publication173238,2025-07-27T15:08:23.043939
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants,Journal of Thrombosis and Haemostasis,2003,10.1046/j.1538-7836.2003.00364.x,https://experts.mcmaster.ca/display/publication173248,2025-07-27T15:08:23.043940
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen,Journal of Thrombosis and Haemostasis,2003,10.1046/j.1538-7836.2003.00241.x,https://experts.mcmaster.ca/display/publication173252,2025-07-27T15:08:23.043942
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Flow cytometric measurement of intracellular IFN-gamma induction in aged subjects before and after parenteral influenza vaccination.,Developments in Biologicals,2003,,https://experts.mcmaster.ca/display/publication1747329,2025-07-27T15:08:23.043943
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,"Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months",Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research,2003,10.1159/000081508,https://experts.mcmaster.ca/display/publication173228,2025-07-27T15:08:23.043944
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.,Haematologica,2002,,https://experts.mcmaster.ca/display/publication173270,2025-07-27T15:08:23.043946
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Influenza A Virus Specific T Cell Immunity in Humans during Aging,Virology,2002,10.1006/viro.2002.1491,https://experts.mcmaster.ca/display/publication411197,2025-07-27T15:08:23.043947
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis,New England Journal of Medicine,2001,10.1056/nejm200107193450302,https://experts.mcmaster.ca/display/publication173284,2025-07-27T15:08:23.043948
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery,JAMA Internal Medicine,2000,10.1001/archinte.160.15.2327,https://experts.mcmaster.ca/display/publication173290,2025-07-27T15:08:23.043950
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Mesenteric-portal Vein Thrombosis in a Patient with Hyperhomocysteinemia and Heterozygous for 20210A Prothrombin Allele,Thrombosis and Haemostasis,2000,10.1055/s-0037-1614025,https://experts.mcmaster.ca/display/publication173289,2025-07-27T15:08:23.043951
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity,Thrombosis and Haemostasis,2000,10.1055/s-0037-1613916,https://experts.mcmaster.ca/display/publication173292,2025-07-27T15:08:23.043952
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery,Investigative Urology,1999,10.1097/00005392-199910000-00130,https://experts.mcmaster.ca/display/publication3461864,2025-07-27T15:08:23.043953
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery,Investigative Urology,1999,10.1016/s0022-5347(05)68386-3,https://experts.mcmaster.ca/display/publication3461872,2025-07-27T15:08:23.043955
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Withdrawal of warfarin after deep vein thrombosis,Blood Coagulation and Fibrinolysis,1999,10.1097/00001721-199907000-00011,https://experts.mcmaster.ca/display/publication173299,2025-07-27T15:08:23.043956
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery,Obstetrical and Gynecological Survey,1998,10.1097/00006254-199811000-00013,https://experts.mcmaster.ca/display/publication3461863,2025-07-27T15:08:23.043958
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery,New England Journal of Medicine,1998,10.1056/nejm199807093390204,https://experts.mcmaster.ca/display/publication173307,2025-07-27T15:08:23.043960
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism,Blood Coagulation and Fibrinolysis,1997,10.1097/00001721-199706000-00002,https://experts.mcmaster.ca/display/publication995612,2025-07-27T15:08:23.043961
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.,Blood Coagulation and Fibrinolysis,1997,10.1097/00001721-199706000-00002,https://experts.mcmaster.ca/display/publication173310,2025-07-27T15:08:23.043962
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis,Clinical Pharmacokinetics,1997,10.2165/00003088-199732020-00005,https://experts.mcmaster.ca/display/publication173315,2025-07-27T15:08:23.043964
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents,Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research,1997,10.1159/000217438,https://experts.mcmaster.ca/display/publication173312,2025-07-27T15:08:23.043965
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Post-discharge deep-vein thrombosis after orthopaedic surgery,The Lancet,1996,10.1016/s0140-6736(05)65324-x,https://experts.mcmaster.ca/display/publication173317,2025-07-27T15:08:23.043966
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Increased Plasma Levels of Tissue Factor Pathway Inhibitor (TFPI) after n-3 Polyunsaturated Fatty Acids Supplementation in Patients with Chronic Atherosclerotic Disease,Thrombosis and Haemostasis,1996,10.1055/s-0038-1650285,https://experts.mcmaster.ca/display/publication173319,2025-07-27T15:08:23.043968
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Post Discharge Clinically Overt Venous Thromboembolism in Orthopaedic Surgery Patients with Negative Venography -an Overview Analysis,Thrombosis and Haemostasis,1996,10.1055/s-0038-1650681,https://experts.mcmaster.ca/display/publication173316,2025-07-27T15:08:23.043969
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins,Circulation,1995,10.1161/01.cir.92.10.2819,https://experts.mcmaster.ca/display/publication173320,2025-07-27T15:08:23.043971
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.,Translational Research,1995,,https://experts.mcmaster.ca/display/publication173321,2025-07-27T15:08:23.043972
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Dermatan sulphate in heparin-induced thrombocytopenia,The Lancet,1994,10.1016/s0140-6736(94)90780-3,https://experts.mcmaster.ca/display/publication173322,2025-07-27T15:08:23.043973
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications,Seminars in Thrombosis and Hemostasis,1994,10.1055/s-2007-1001912,https://experts.mcmaster.ca/display/publication173323,2025-07-27T15:08:23.043975
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Antipyretic analgesics,Side Effects of Drugs Annual,1994,10.1016/s0378-6080(05)80253-3,https://experts.mcmaster.ca/display/publication1747354,2025-07-27T15:08:23.043976
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Streptokinase and rt-PA activate platelets by a different way: Implications on the rethrombosis rate after their administration in myocardial infarction,Fibrinolysis and Proteolysis,1994,10.1016/0268-9499(94)90489-8,https://experts.mcmaster.ca/display/publication3461868,2025-07-27T15:08:23.043977
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Fibrinogen degradation products generation is the major determinant of platelet inhibition induced by plasminogen activators in platelet-rich plasma,Fibrinolysis and Proteolysis,1993,10.1016/0268-9499(93)90062-z,https://experts.mcmaster.ca/display/publication995622,2025-07-27T15:08:23.043979
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Thrombolytic and haemorrhagic effects of bolus doses of rt-PA and A hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935),Thrombosis Research,1993,10.1016/0049-3848(93)90428-q,https://experts.mcmaster.ca/display/publication3461873,2025-07-27T15:08:23.043980
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB2629: LATE DIAGNOSIS OF TWO ADULT SIBLINGS WITH BERNARD SOULIER SYNDROME (BSS),HemaSphere,,10.1097/01.hs9.0000977204.63685.a6,https://experts.mcmaster.ca/display/publication3461840,2025-07-27T15:08:23.043982
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,PB2647: USE OF EMICIZUMAB FOR THE TREATMENT OF ACQUIRED HEMOPHILIA A: A SYSTEMATIC REVIEW,HemaSphere,,10.1097/01.hs9.0000977272.39179.7d,https://experts.mcmaster.ca/display/publication3461841,2025-07-27T15:08:23.043983
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Psychological interventions for people with hemophilia,Cochrane Database of Systematic Reviews,,10.1002/14651858.cd010215,https://experts.mcmaster.ca/display/publication3461865,2025-07-27T15:08:23.043984
Alfonso Iorio,iorioa@mcmaster.ca,journal_articles,Reflections on the Canadian Bleeding Disorders Registry: Lessons Learned and Future Perspectives,Canadian Journal of Health Technologies,,10.51731/cjht.2022.425,https://experts.mcmaster.ca/display/publication2716670,2025-07-27T15:08:23.043986
Alfonso Iorio,iorioa@mcmaster.ca,chapters,Non-Anticoagulant Actions of Glycosaminoglycans,,1996,10.1007/978-1-4613-0371-8_8,https://experts.mcmaster.ca/display/publication3461866,2025-07-27T15:08:23.043988
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study,Haemophilia,2024,10.1111/hae.14969,https://experts.mcmaster.ca/display/publication995654,2025-07-27T15:08:23.043990
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Characterisation of the first global VWD cohort from the WFH world bleeding disorders registry,Haemophilia,2024,,https://experts.mcmaster.ca/display/publication3513406,2025-07-27T15:08:23.043991
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Evolution of haemophilia care: Analysing factor VIII usage trends and the impact of novel therapies,Haemophilia,2024,,https://experts.mcmaster.ca/display/publication3513404,2025-07-27T15:08:23.043992
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Gene therapy with the Padua variant of a codon-optimised human factor IX gene etranacogene dezaparvovec in people with haemophilia B: Effects on patient-oriented outcomes measured using the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire in the HOPE-B study",Haemophilia,2024,,https://experts.mcmaster.ca/display/publication3513402,2025-07-27T15:08:23.043994
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Real-world effectiveness of pegylated, recombinant antihaemophilic factor (Rurioctocog alfa pegol) prophylaxis in patients with haemophilia A in Canada: A retrospective, intra-patient comparison with a before-after design",Haemophilia,2024,,https://experts.mcmaster.ca/display/publication3513405,2025-07-27T15:08:23.043995
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Self-reflections, lessons learned and suggestions for data quality assurance from a retrospective data analysis from the Canadian Bleeding Disorders Registry",Haemophilia,2024,,https://experts.mcmaster.ca/display/publication3513403,2025-07-27T15:08:23.043997
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Comparing inhibitor development in (plasma derived vs. recombinant) FVIII/FIX concentrates in severe haemophilia: Reporting on 1392 PUPs from EUHASS and canadian registries,Haemophilia,2024,,https://experts.mcmaster.ca/display/publication3429332,2025-07-27T15:08:23.043998
Alfonso Iorio,iorioa@mcmaster.ca,conferences,International data integration program of the WFH world bleeding disorders registry: bringing europe data to the global stage,Haemophilia,2024,,https://experts.mcmaster.ca/display/publication3429333,2025-07-27T15:08:23.044003
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry,Blood,2023,10.1182/blood-2023-174057,https://experts.mcmaster.ca/display/publication3403139,2025-07-27T15:08:23.044005
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"A COMPARATIVE STUDY OF DIFFERENT METHODS OF HANDLING MISSING DATA IN PATIENT REPORTED OUTCOMES, BURDENS AND EXPERIENCES (PROBE) SCORE ALGORITHM AMONG PEOPLE WITH HEMOPHILIA",American Journal of Hematology,2023,,https://experts.mcmaster.ca/display/publication2980744,2025-07-27T15:08:23.044006
Alfonso Iorio,iorioa@mcmaster.ca,conferences,BUILDING A GLOBAL RESOURCE FOR THE LONG-TERM FOLLOW-UP OF HEMOPHILIA PATIENTS TREATED WITH GENE THERAPY: COLLABORATION BETWEEN THE WORLD FEDERATION OF HEMOPHILIA AND NATIONAL REGISTRIES,Haemophilia,2023,,https://experts.mcmaster.ca/display/publication3282185,2025-07-27T15:08:23.044007
Alfonso Iorio,iorioa@mcmaster.ca,conferences,COLLABORATION FOR THE LONG-TERM FOLLOW-UP OF PEOPLE WITH HEMOPHILIA TREATED WITH GENE THERAPY: WORLD FEDERATION OF HEMOPHILIA- AMERICAN THROMBOSIS AND HEMOSTASIS NETWORK,American Journal of Hematology,2023,,https://experts.mcmaster.ca/display/publication2981099,2025-07-27T15:08:23.044009
Alfonso Iorio,iorioa@mcmaster.ca,conferences,TEST-RETEST RELIABILITY ANALYSIS OF THE PATIENT REPORTED OUTCOMES BURDENS AND EXPERIENCES (PROBE) STUDY,Haemophilia,2023,,https://experts.mcmaster.ca/display/publication3281999,2025-07-27T15:08:23.044014
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry,Blood,2022,10.1182/blood-2022-157531,https://experts.mcmaster.ca/display/publication2922803,2025-07-27T15:08:23.044016
Alfonso Iorio,iorioa@mcmaster.ca,conferences,COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS,Value in Health,2022,,https://experts.mcmaster.ca/display/publication2424575,2025-07-27T15:08:23.044017
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Comparison of change in number of identified people with haemophilia A and factor VIII use per patient over time,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2188826,2025-07-27T15:08:23.044019
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Empowering people with haemophilia to take control of their care and treatment through myWBDR and myPROBE-A patient-reported outcomes tool for achieving a 360-degree patient-centred evaluation,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2187647,2025-07-27T15:08:23.044020
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Feasibility of integrating PROBE (patient reported outcomes, burdens and experiences) into a clinical care pathway to facilitate transformation to a value-based health care model in haemophilia",Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2187650,2025-07-27T15:08:23.044021
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Integration of the Mexican Registry of Coagulopathies (RMC) with PROBE,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2187649,2025-07-27T15:08:23.044023
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Prevalence of selected bleeding and thrombotic events in persons with congenital haemophilia versus the general non-haemophilia population,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2188825,2025-07-27T15:08:23.044024
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Using the World Federation of Haemophilia gene therapy registry for the long-term follow-up of haemophilia patients treated with gene therapy,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2187651,2025-07-27T15:08:23.044025
Alfonso Iorio,iorioa@mcmaster.ca,conferences,WFH world bleeding disorders registry highlights gaps in haemophilia diagnosis and management,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2188824,2025-07-27T15:08:23.044027
Alfonso Iorio,iorioa@mcmaster.ca,conferences,CANADIAN CLINICAL EXPERIENCE ON SWITCHING FROM OCTOCOG ALFA TO EXTENDED-HALF-LIFE FVIII DAMOCTOCOG ALFA PEGOL IN PATIENTS WITH SEVERE HAEMOPHILIA A,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2165640,2025-07-27T15:08:23.044028
Alfonso Iorio,iorioa@mcmaster.ca,conferences,THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY - A GLOBAL RESOURCE FOR THE LONG-TERM FOLLOW-UP OF HEMOPHILIA PATIENTS TREATED WITH GENE THERAPY,Haemophilia,2022,,https://experts.mcmaster.ca/display/publication2165639,2025-07-27T15:08:23.044029
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry,Blood,2021,10.1182/blood-2021-147195,https://experts.mcmaster.ca/display/publication2427707,2025-07-27T15:08:23.044031
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study,Blood,2021,10.1182/blood-2021-147550,https://experts.mcmaster.ca/display/publication2428077,2025-07-27T15:08:23.044032
Alfonso Iorio,iorioa@mcmaster.ca,conferences,ANALYSIS OF HEMOPHILIA PATIENT IDENTIFICATION IN DIFFERENT ECONOMIC SETTINGS,Haemophilia,2021,,https://experts.mcmaster.ca/display/publication1962896,2025-07-27T15:08:23.044033
Alfonso Iorio,iorioa@mcmaster.ca,conferences,EQUITY IN THE USE OF PROPHYLAXIS IN CHILDREN WITH SEVERE HEMOPHILIA,Haemophilia,2021,,https://experts.mcmaster.ca/display/publication1962898,2025-07-27T15:08:23.044035
Alfonso Iorio,iorioa@mcmaster.ca,conferences,THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY,Haemophilia,2021,,https://experts.mcmaster.ca/display/publication1962004,2025-07-27T15:08:23.044036
Alfonso Iorio,iorioa@mcmaster.ca,conferences,WORLD BLEEDING DISORDERS REGISTRY SHOWCASES DISPARITIES IN HEMOPHILIA CARE AROUND THE WORLD,Haemophilia,2021,,https://experts.mcmaster.ca/display/publication1962897,2025-07-27T15:08:23.044037
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry,Blood,2020,10.1182/blood-2020-137320,https://experts.mcmaster.ca/display/publication1963023,2025-07-27T15:08:23.044039
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database,Blood,2020,10.1182/blood-2020-142816,https://experts.mcmaster.ca/display/publication3434164,2025-07-27T15:08:23.044040
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A,Blood,2020,10.1182/blood-2020-136586,https://experts.mcmaster.ca/display/publication3434165,2025-07-27T15:08:23.044041
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments,Blood,2020,10.1182/blood-2020-141801,https://experts.mcmaster.ca/display/publication3434163,2025-07-27T15:08:23.044043
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Comparative PK evaluation of SHL vs EHL by non-compartmental and compartmental population PK analysis in patients with severe and moderate HA,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1914750,2025-07-27T15:08:23.044044
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Data is the new currency: The World Bleeding Disorders Registry Data Quality Accreditation Program,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1914744,2025-07-27T15:08:23.044046
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Education in people with Hemophilia - Insights from the PROBE Study,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1914746,2025-07-27T15:08:23.044047
Alfonso Iorio,iorioa@mcmaster.ca,conferences,International Standard Set of Health Outcomes that matter for people living with hemophilia,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1914745,2025-07-27T15:08:23.044049
Alfonso Iorio,iorioa@mcmaster.ca,conferences,What the future might look like-The PROBE Study,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1894316,2025-07-27T15:08:23.044050
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"ASSESSING A POPULATION PHARMACOKINETIC MODEL OF A PLASMA-DERIVED, VON WILLEBRAND FACTOR-CONTAINING FVIII CONCENTRATE FOR BAYESIAN FORECASTING IN LOW DOSE SCENARIOS",Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1694212,2025-07-27T15:08:23.044055
Alfonso Iorio,iorioa@mcmaster.ca,conferences,DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1692273,2025-07-27T15:08:23.044056
Alfonso Iorio,iorioa@mcmaster.ca,conferences,INTERNATIONAL STANDARD SET OF HEALTH OUTCOMES THAT MATTER FOR PEOPLE LIVING WITH HEMOPHILIA,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1692275,2025-07-27T15:08:23.044058
Alfonso Iorio,iorioa@mcmaster.ca,conferences,PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1694213,2025-07-27T15:08:23.044059
Alfonso Iorio,iorioa@mcmaster.ca,conferences,REPORT ON THE ANNUAL GLOBAL SURVEY-20 YEARS ON AND MORE INFORMATIVE,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1694211,2025-07-27T15:08:23.044060
Alfonso Iorio,iorioa@mcmaster.ca,conferences,THE WORLD BLEEDING DISORDERS REGISTRY CELEBRATES 2 YEARS!,Haemophilia,2020,,https://experts.mcmaster.ca/display/publication1694210,2025-07-27T15:08:23.044062
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A,Blood,2019,10.1182/blood-2019-127046,https://experts.mcmaster.ca/display/publication1942922,2025-07-27T15:08:23.044063
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products,Blood,2019,10.1182/blood-2019-127946,https://experts.mcmaster.ca/display/publication1942921,2025-07-27T15:08:23.044064
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Routine Double Filtration Plasmapheresis Affects Hemostatic Proteins and Prolongs Clotting Tests,Blood,2019,10.1182/blood-2019-127524,https://experts.mcmaster.ca/display/publication1942080,2025-07-27T15:08:23.044066
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization,Journal of Pharmacokinetics and Pharmacodynamics,2019,10.1007/s10928-019-09634-7,https://experts.mcmaster.ca/display/publication1500755,2025-07-27T15:08:23.044067
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients,Journal of Pharmacokinetics and Pharmacodynamics,2019,10.1007/s10928-019-09637-4,https://experts.mcmaster.ca/display/publication1600586,2025-07-27T15:08:23.044068
Alfonso Iorio,iorioa@mcmaster.ca,conferences,PROSPECTIVE STUDY OF THE IMMUNOLOGICAL RES PONSE TO FACTOR VIII IN SEVERE HEMOPHILIA A PATIENTS DURING IMMUNE TOLERANCE INDUCTION TREATMENT,Haematologica,2019,,https://experts.mcmaster.ca/display/publication1671698,2025-07-27T15:08:23.044070
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"coreHEM, a Multistakeholder Core Outcome Set Project for Gene Therapy in Hemophilia",Molecular Therapy,2019,,https://experts.mcmaster.ca/display/publication1639464,2025-07-27T15:08:23.044071
Alfonso Iorio,iorioa@mcmaster.ca,conferences,ASSESSMENT OF PHARMACOKINETIC BAYESIAN PREDICTIONS IN HEMOPHILIA B USING LIMITED SAMPLING ANALYSIS.,Clinical Pharmacology and Therapeutics,2019,,https://experts.mcmaster.ca/display/publication1632300,2025-07-27T15:08:23.044072
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Part-time employment and early retirement in people with severe haemophilia: Insights from the PROBE study,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1628469,2025-07-27T15:08:23.044074
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Predictors for acute and chronic pain in patients with severe haemophilia in the PROBE cohort,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1628470,2025-07-27T15:08:23.044075
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The WFH world bleeding disorders registry,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1629942,2025-07-27T15:08:23.044076
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The Web-Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-HEMO) contribution to tailoring treatment in children: Examples for hemophilia A and B,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1629941,2025-07-27T15:08:23.044077
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Using individual pharmacokinetic parameters on octocog alfa to predict individual pharmacokinetic parameters on efmoroctocog alfa in persons with hemophilia A,Haemophilia,2019,,https://experts.mcmaster.ca/display/publication1629943,2025-07-27T15:08:23.044079
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform,Blood,2018,10.1182/blood-2018-99-115308,https://experts.mcmaster.ca/display/publication1632298,2025-07-27T15:08:23.044080
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada,Blood,2018,10.1182/blood-2018-99-113858,https://experts.mcmaster.ca/display/publication1632119,2025-07-27T15:08:23.044081
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study,Blood,2018,10.1182/blood-2018-99-119568,https://experts.mcmaster.ca/display/publication1630926,2025-07-27T15:08:23.044083
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of anti-hemophilic factor recombinant plasma/albumin-free method (rAHF-PFM) concentrate in patients with Hemophilia A,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1541344,2025-07-27T15:08:23.044084
Alfonso Iorio,iorioa@mcmaster.ca,conferences,First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem,Value in Health,2018,10.1016/j.jval.2018.04.1439,https://experts.mcmaster.ca/display/publication1581308,2025-07-27T15:08:23.044085
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The PROBE Data Dashboard - A new tool for real-time data visualization and analysis of patient reported outcomes,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543698,2025-07-27T15:08:23.044087
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The PROBE Study - Global burden of bleeding from the mouth in Haemophilia - a call to action,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543701,2025-07-27T15:08:23.044088
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The WFH World Bleeding Disorders Registry,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543700,2025-07-27T15:08:23.044089
Alfonso Iorio,iorioa@mcmaster.ca,conferences,coreHEM: A multi-stakeholder approach to developing a core outcome set for gene therapy in hemophilia,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543702,2025-07-27T15:08:23.044091
Alfonso Iorio,iorioa@mcmaster.ca,conferences,eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1543699,2025-07-27T15:08:23.044092
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of factor VIII concentrate in patients with hemophilia A,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1498587,2025-07-27T15:08:23.044093
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study",Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1498586,2025-07-27T15:08:23.044095
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1498585,2025-07-27T15:08:23.044096
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Perioperative management for patients with congenital factor XI deficiency,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1498588,2025-07-27T15:08:23.044097
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The WFH world bleeding disorders registry,Haemophilia,2018,,https://experts.mcmaster.ca/display/publication1498589,2025-07-27T15:08:23.044099
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study",Blood,2017,,https://experts.mcmaster.ca/display/publication1979440,2025-07-27T15:08:23.044100
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Comparative Assessment of the Performance of Pharmacokinetic Tools for Prophylactic Dosing of Antihemophilic Factor Recombinant Plasma/Albumin-Free Method (rAHF-PFM) Concentrate in Patients with Hemophilia A,Blood,2017,,https://experts.mcmaster.ca/display/publication3272670,2025-07-27T15:08:23.044101
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a,Blood,2017,,https://experts.mcmaster.ca/display/publication1589072,2025-07-27T15:08:23.044102
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study,Blood,2017,,https://experts.mcmaster.ca/display/publication3272671,2025-07-27T15:08:23.044104
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study",Blood,2017,,https://experts.mcmaster.ca/display/publication1979441,2025-07-27T15:08:23.044105
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The Development of the World Bleeding Disorders Registry Pilot Phase,Haemophilia,2017,,https://experts.mcmaster.ca/display/publication995663,2025-07-27T15:08:23.044106
Alfonso Iorio,iorioa@mcmaster.ca,conferences,An individual participant data meta-analysis of 13 randomized trials to evaluate the impact of prophylactic use of heparin in oncological patients,Blood,2017,10.1182/blood.v130.suppl_1.626.626,https://experts.mcmaster.ca/display/publication1563461,2025-07-27T15:08:23.044108
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome,Arthritis & Rheumatology,2017,,https://experts.mcmaster.ca/display/publication1471695,2025-07-27T15:08:23.044109
Alfonso Iorio,iorioa@mcmaster.ca,conferences,THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome,Annals of the Rheumatic Diseases,2017,10.1136/annrheumdis-2017-eular.2085,https://experts.mcmaster.ca/display/publication1477831,2025-07-27T15:08:23.044110
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis,Journal of Thrombosis and Haemostasis,2017,10.1111/jth.14824,https://experts.mcmaster.ca/display/publication1563464,2025-07-27T15:08:23.044112
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Clinical and Biological Determinants of Bleeding Manifestation in Congenital Factor XI Deficiency; A Systematic Review,Blood,2016,10.1182/blood.v128.22.1407.1407,https://experts.mcmaster.ca/display/publication995657,2025-07-27T15:08:23.044113
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Installing FVIII-Specific Tolerance in Hemophilia Via Engagement of the Aryl Hydrocarbon Receptor By Tryptophan Derivatives,Blood,2016,10.1182/blood.v128.22.2563.2563,https://experts.mcmaster.ca/display/publication995659,2025-07-27T15:08:23.044114
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)",Blood,2016,10.1182/blood.v128.22.2593.2593,https://experts.mcmaster.ca/display/publication995656,2025-07-27T15:08:23.044115
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Perioperative Management for Congenital Factor XI Deficiency; A Systematic Review,Blood,2016,10.1182/blood.v128.22.3796.3796,https://experts.mcmaster.ca/display/publication995658,2025-07-27T15:08:23.044117
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Perioperative Management of Von Willebrand Disease, a Systematic Review and Meta-Analysis",Blood,2016,10.1182/blood.v128.22.1408.1408,https://experts.mcmaster.ca/display/publication995664,2025-07-27T15:08:23.044118
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Rwd Study for Epidemiology and Characteristics of Patients with Multiple Myeloma in Italy,Blood,2016,10.1182/blood.v128.22.5693.5693,https://experts.mcmaster.ca/display/publication995652,2025-07-27T15:08:23.044119
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Test-Retest Reliability Analysis of the Patient Reported Outcomes Burdens and Experiences (PROBE),Blood,2016,10.1182/blood.v128.22.5964.5964,https://experts.mcmaster.ca/display/publication995651,2025-07-27T15:08:23.044121
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The Effect of Platelet Transfusion on Death in the Intensive Care Unit,Blood,2016,10.1182/blood.v128.22.3850.3850,https://experts.mcmaster.ca/display/publication554330,2025-07-27T15:08:23.044126
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis,Blood,2016,10.1182/blood.v128.22.3821.3821,https://experts.mcmaster.ca/display/publication710721,2025-07-27T15:08:23.044128
Alfonso Iorio,iorioa@mcmaster.ca,conferences,NHF-MCMASTER GUIDELINE ON CARE MODELS FOR HEMOPHILIA MANAGEMENT,American Journal of Hematology,2016,,https://experts.mcmaster.ca/display/publication626825,2025-07-27T15:08:23.044129
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Hemophilia research and clinical care needs: Regional variation in future priorities,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995672,2025-07-27T15:08:23.044130
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Home therapy consensus in an under resourced hemophilia setting,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995680,2025-07-27T15:08:23.044132
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Measuring the quality of hemophilia care across different settings: a set of performance indices derived from demographics data,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995671,2025-07-27T15:08:23.044133
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The patient reported outcomes burdens and experiences (PROBE) study phase 1 methodology and feasibility results,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995670,2025-07-27T15:08:23.044135
Alfonso Iorio,iorioa@mcmaster.ca,conferences,When health care professionals express themselves: results overview of the qualitative phase of Hero initiative,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995673,2025-07-27T15:08:23.044136
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The patient reported outcome burdens and experiences (PROBE) study - phase 1 results show PROBE study methodology feasible,Journal of Thrombosis and Haemostasis,2016,,https://experts.mcmaster.ca/display/publication995693,2025-07-27T15:08:23.044137
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Evidence Based Haemophilia Care - Current Status and Where to Go?,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995697,2025-07-27T15:08:23.044139
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Haemophilia Research and Clinical Care Needs: Assessing Future Priorities,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995701,2025-07-27T15:08:23.044140
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Health Status of Elderly Persons with Hemophilia Compared with the General Population: The Sphera Study,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995683,2025-07-27T15:08:23.044141
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Nonacog Alfa as Prophylaxis in Moderately Severe to Severe (FIX:C <= 2%) Hemophilia B Patients: Identifying Clinical Predictors of Response,Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995700,2025-07-27T15:08:23.044143
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"The Patient Reported Outcomes, Burdens, and Experiences (Probe) Phase 1 Study Methodology and Feasibility",Haemophilia,2016,,https://experts.mcmaster.ca/display/publication995689,2025-07-27T15:08:23.044144
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis,Blood,2015,10.1182/blood.v126.23.1120.1120,https://experts.mcmaster.ca/display/publication440320,2025-07-27T15:08:23.044145
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors,Blood,2015,10.1182/blood.v126.23.428.428,https://experts.mcmaster.ca/display/publication440317,2025-07-27T15:08:23.044147
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Safety and Effectiveness of Desmopressin for the Management of Delivery and Major Surgery in Patients with Mild-Moderate Von Willebrand Disease: Final Analysis of the Prodeswil Study,Blood,2015,10.1182/blood.v126.23.759.759,https://experts.mcmaster.ca/display/publication995699,2025-07-27T15:08:23.044148
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis,Blood,2015,10.1182/blood.v126.23.430.430,https://experts.mcmaster.ca/display/publication440289,2025-07-27T15:08:23.044149
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Study Design: A Critical Aspect of Research,Haemophilia,2015,,https://experts.mcmaster.ca/display/publication995719,2025-07-27T15:08:23.044151
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Web Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-Hemo): A Service for Bayesian Post Hoc Estimation,Journal of Pharmacokinetics and Pharmacodynamics,2015,,https://experts.mcmaster.ca/display/publication995695,2025-07-27T15:08:23.044152
Alfonso Iorio,iorioa@mcmaster.ca,conferences,A population approach to hemophilia pharmacokinetics. Wapps: a web-service for bayesian post hoc estimation,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication623885,2025-07-27T15:08:23.044153
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Assessing the indication and success of treatment for haemophilia patients: results from a delphi panel,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication995716,2025-07-27T15:08:23.044154
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Bayesian approach to the assessment of the population specific risk of inhibitors,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication623879,2025-07-27T15:08:23.044156
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Determinants of inhibitor development in previously treated hemophilia A patients,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication771728,2025-07-27T15:08:23.044157
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Indirect comparisons of factor consumption, bleeding rates, and infusion frequencies during routine prophylaxis with recombinant factor IX FC fusion protein and other recombinant factor IX products",Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication995704,2025-07-27T15:08:23.044158
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Indirect comparisons of factor consumption, bleeding rates, and infusion frequencies during routine prophylaxis with recombinant factor VIII FC fusion protein and other recombinant factor VIII products",Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication995708,2025-07-27T15:08:23.044160
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Investigating potential determinants of ITI success using immune gene expression profiling: a preliminary study,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication995702,2025-07-27T15:08:23.044161
Alfonso Iorio,iorioa@mcmaster.ca,conferences,OPTIMAL DURATION OF ANTICOAGULANT THERAPY FOR THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS,Haematologica,2015,,https://experts.mcmaster.ca/display/publication995712,2025-07-27T15:08:23.044162
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Pharmacokinetic characteristics of factor VIII and IX concentrates - a systematic review,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication623901,2025-07-27T15:08:23.044164
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Surveillance study of safety and efficacy of a VWF/FVIII concentrate in patients with von willebrand disease (WIL-20) - a planned interim analysis,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication995707,2025-07-27T15:08:23.044165
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Utilization of anti-inhibitors products and inhibitors status of severe hemophilia patients: 5 years national data from the Canadian hemophilia assessment and resource management system,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication995703,2025-07-27T15:08:23.044166
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Population pharmacokinetics for busy clinicians and active patients: how to get the most out of it?,Haemophilia,2015,,https://experts.mcmaster.ca/display/publication995737,2025-07-27T15:08:23.044167
Alfonso Iorio,iorioa@mcmaster.ca,conferences,A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia,Blood,2014,10.1182/blood.v124.21.2821.2821,https://experts.mcmaster.ca/display/publication623891,2025-07-27T15:08:23.044169
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients,Journal of Thrombosis and Haemostasis,2014,,https://experts.mcmaster.ca/display/publication771740,2025-07-27T15:08:23.044170
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Risk of inhibitor development in previously treated patients with positive inhibitor history or low titer of inhibitor at baseline: results of a survey of hemophilia experts,Journal of Thrombosis and Haemostasis,2014,,https://experts.mcmaster.ca/display/publication623977,2025-07-27T15:08:23.044171
Alfonso Iorio,iorioa@mcmaster.ca,conferences,An evaluation of whether the ankle is now the dominant site of chronic hemophilic arthropathy in young adults with severe hemophilia,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995759,2025-07-27T15:08:23.044173
Alfonso Iorio,iorioa@mcmaster.ca,conferences,An indirect comparison of the efficacy of prophylactic use of rFIXFc and other rFIX products and simulation of the effect of compliance on effectiveness,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995755,2025-07-27T15:08:23.044174
Alfonso Iorio,iorioa@mcmaster.ca,conferences,An indirect comparison of the efficacy of prophylactic use of rFVIIIFc and other rFVIII products and model of the effect of compliance,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995747,2025-07-27T15:08:23.044175
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Assessment of patient preferences and perceived value of the comprehensive interdisciplinary combined hemophilia and orthopedic clinic using a validated questionnaire,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication959070,2025-07-27T15:08:23.044177
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Cardiac risk factors in older patients with hemophilia: Report of the age related cardiovascular disease in hemophilia epidemiologic research (archer) study,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995760,2025-07-27T15:08:23.044178
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Factor VII deficiency patients: 5 years factors concentrates utilization trend based on the Canadian Hemophilia Assessment and Resource Management System (CHARMS),Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995752,2025-07-27T15:08:23.044179
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Factors influencing quality of life in Chinese adults with hemophilia: Results from the HERO study,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995728,2025-07-27T15:08:23.044181
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Fathers' and Mothers' Perceptions and Communication on Carrier Status and Diagnosis of Congenital Haemophilia: Global Results from the Haemophilia Experiences, Results and Opportunities (HERO) Study",Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995725,2025-07-27T15:08:23.044182
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Investigating Attitudes and Practices of Canadian Physiotherapists on Sexual Health: A Comparison to the HERO Dataset,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995726,2025-07-27T15:08:23.044183
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Physiotherapy and point of care ultrasonography in the management of hemophilia: Training phase,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication959071,2025-07-27T15:08:23.044184
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Safety of antihemophilic factor recombinant plasma/albumin-free method [rAHF-PFM] in hemophilia A patients with low titer inhibitors or a personal history of inhibitor: A meta-analysis of ADVATE Post-Authorization Safety Studies data,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication624036,2025-07-27T15:08:23.044186
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Does product type influence the development on inhibitor in PTPs and PUPs?,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995756,2025-07-27T15:08:23.044187
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Does product type influence the development on inhibitor in PTPs and PUPs?,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication995770,2025-07-27T15:08:23.044188
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication771722,2025-07-27T15:08:23.044190
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The use of FVIII concentrate in hemophilia A patients with low titer inhibitors or a personal history of inhibitor: a meta-analysis of advate post-authorization safety studies in different countries,Haemophilia,2014,,https://experts.mcmaster.ca/display/publication624005,2025-07-27T15:08:23.044191
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Venous thromboembolism prophylaxis in elderly patients admitted to Italian internal medicine wards,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995769,2025-07-27T15:08:23.044192
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Developing a Two-Sided Intervention To Facilitate Shared Decision Making In Haemophilia: Decision Boxes For Clinicians and Brief Patient Decision Aids For Patients,Blood,2013,,https://experts.mcmaster.ca/display/publication771741,2025-07-27T15:08:23.044194
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Association between treatment regimen and quality of life assessed by EQ-5D-3L and pain interference in adults with haemophilia with and without inhibitors in the HERO study,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995741,2025-07-27T15:08:23.044195
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Association of treatment regimen and location with bleed frequency, quality of life and comorbidities in adults and children with haemophilia from the HERO study",Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995749,2025-07-27T15:08:23.044197
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia A patients carrying F8 gene null mutations",Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995750,2025-07-27T15:08:23.044198
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Do bleed rates and haemophilia treatment centre/provider utilisation vary with physical activity risk in adults with haemophilia: An analysis from the HERO study,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995746,2025-07-27T15:08:23.044200
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Do inhibitors, treatment regimen and bleed frequency impact haemophilia treatment centre and provider utilisation: an analysis of adults with haemophilia in the HERO study",Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995758,2025-07-27T15:08:23.044201
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Do inhibitors, treatment regimen and bleed frequency impact parent-directed haemophilia treatment centre and provider utilisation: An analysis of parents of children with haemophilia in the HERO study",Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995742,2025-07-27T15:08:23.044203
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Does higher risk activity change bleed frequency and haemophilia treatment center/provider utilisation in children with haemophilia: an analysis from the HERO study,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995748,2025-07-27T15:08:23.044204
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Effect of type and intensity of FVIII exposure on inhibitors development in hemophilia A: first results of an individual patient data meta-analytic project,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995751,2025-07-27T15:08:23.044205
Alfonso Iorio,iorioa@mcmaster.ca,conferences,External validation and updating of the Vienna Prediction Model for recurrent venous thromboembolism using a pooled individual patient data database,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995743,2025-07-27T15:08:23.044207
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Meta-analysis of Post Authorization Safety Studies: worldwide postmarking surveillance of hemophilia A patients treated with antihemophilic factor recombinant plasma/albumin-free method rAHF-PFM,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication624017,2025-07-27T15:08:23.044208
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Potential relationships between negative impacts on employment or relationships and haemophilia treatment centre/provider utilisation: an analysis of adults with haemophilia from the HERO study,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995754,2025-07-27T15:08:23.044210
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Potential relationships between negative impacts on employment or relationships with haemophilia centre/provider utilisation: An analysis of parents of children with haemophilia from the HERO study,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995753,2025-07-27T15:08:23.044211
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Quality of life and well-being of haemophilia patients and parents in China: subgroup analysis of the HERO study,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995757,2025-07-27T15:08:23.044212
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Relationship of quality of life, pain and self-reported arthritis with activity, bleed rate and haemophilia treatment centre/provider utilisation: results from the HERO study",Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication995745,2025-07-27T15:08:23.044214
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Access to haemophilia treatment centres (HTCS), treatment and information sources: european results from the hero study",Haemophilia,2013,,https://experts.mcmaster.ca/display/publication995771,2025-07-27T15:08:23.044215
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Demographic characteristics of European respondents in the hero study,Haemophilia,2013,,https://experts.mcmaster.ca/display/publication995776,2025-07-27T15:08:23.044217
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Effect of turoctocog alfa on quality of life of children, adolescents and adults with haemophilia A: results from two clinical trials",Haemophilia,2013,,https://experts.mcmaster.ca/display/publication995765,2025-07-27T15:08:23.044218
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Effects of haemophilia on relationships, intimacy and family: european results from the hero study",Haemophilia,2013,,https://experts.mcmaster.ca/display/publication995764,2025-07-27T15:08:23.044219
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Quality of life in adults with haemophilia: european results from the hero study,Haemophilia,2013,,https://experts.mcmaster.ca/display/publication995767,2025-07-27T15:08:23.044221
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Hemophilia Experiences, Results and Opportunities (HERO) Study: US Respondent Demographics and Impact of Diagnosis On Career and Lifestyle Decisions and Quality of Life",Blood,2012,10.1182/blood.v120.21.4244.4244,https://experts.mcmaster.ca/display/publication995785,2025-07-27T15:08:23.044222
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Assessment of treatment-related risk factors for inhibitor development in previously untreated hemophilia A patients: Different statistical approaches,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995787,2025-07-27T15:08:23.044223
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Clinical presentation and management of adult patients responding to the Hemophilia Experiences Results Opportunities (HERO) study,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995786,2025-07-27T15:08:23.044225
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Clinical presentation and management of pediatric hemophilia patients as reported by parents surveyed in the Haemophilia Experiences Results Opportunities (HERO) survey,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995794,2025-07-27T15:08:23.044226
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Demographic characteristics of adult patient respondents in the Hemophilia Experiences Results Opportunities (HERO) study,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995790,2025-07-27T15:08:23.044227
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Demographic characteristics of parents of children/adolescents with hemophilia responding in the Hemophilia Experiences Results Opportunities (HERO) study,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995793,2025-07-27T15:08:23.044229
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Hemophilia knowledge and frequently used and valued information sources: Patient/parent perceptions from the Hero study,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995788,2025-07-27T15:08:23.044230
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Impact of hemophilia on interpersonal relationships: Assessment of parent/caregiver respondents in the hemophilia experiences, results, opportunities (hero) study",Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995780,2025-07-27T15:08:23.044235
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Impact of hemophilia on relationships with partners, family, and friends: Assessment of adult patient respondents in the hemophilia experiences, results, opportunities (HERO) study",Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995791,2025-07-27T15:08:23.044236
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Low bone mineral density and increased fat mass in boys with severe hemophilia,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication179544,2025-07-27T15:08:23.044237
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Nutritional intake and bone mineral density in boys with severe hemophilia,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication179542,2025-07-27T15:08:23.044239
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Osteochondral Lesions of the Ankle Joint in Patients with Hemophilia A: A Retrospective Case Series,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication179516,2025-07-27T15:08:23.044240
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Predictors of success of immune tolerance induction in hemophilia A patients with high-responding inhibitors: A score from the Italian registry,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995779,2025-07-27T15:08:23.044242
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Qualitative and quantitative assessment of sexual intimacy in adult patients in the hemophilia experiences results opportunities (HERO) study,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995778,2025-07-27T15:08:23.044243
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Quality of life (QOL) and well-being of hemophilia patients and parents managing hemophilia: Hero study analysis,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995792,2025-07-27T15:08:23.044244
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Concentrate type and dose in hemophilia A patients: is there an independent effect on risk of inhibitor formation?,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995805,2025-07-27T15:08:23.044246
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The use of the clinical trial design in Hemophilia: methodological considerations,Haemophilia,2012,,https://experts.mcmaster.ca/display/publication995808,2025-07-27T15:08:23.044247
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study",Blood,2011,,https://experts.mcmaster.ca/display/publication995804,2025-07-27T15:08:23.044248
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score,Blood,2011,,https://experts.mcmaster.ca/display/publication995810,2025-07-27T15:08:23.044250
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Bioequivalence of B-domain deleted and plasma derived FVIII concentrates,Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication995729,2025-07-27T15:08:23.044251
Alfonso Iorio,iorioa@mcmaster.ca,conferences,HERO - an international initiative exploring unmet psychosocial needs in haemophilia: results from a qualitative survey targeting 150 subjects in seven countries,Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication995724,2025-07-27T15:08:23.044252
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"HERO, an international initiative exploring unmet psychosocial needs in haemophilia: characteristics of a quantitative survey targeting 1200 subjects in 12 countries",Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication995731,2025-07-27T15:08:23.044254
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Heterogeneity of the clinical, laboratory and molecular markers of VWD type 3: results from the retrospective/prospective studies on 122/52 Italian patients",Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication995740,2025-07-27T15:08:23.044255
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Impact of persistent antiphospholipid antibodies on symptomatic thromboembolism in children: a systematic review & meta-analysis [observational studies],Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication995736,2025-07-27T15:08:23.044257
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Psychosocial aspects of living with haemophilia: the hero project and a narrative review of the published literature,Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication995738,2025-07-27T15:08:23.044258
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Predictive model to assess the risk of inhibitor development in children with severe and moderate haemophilia A - results of a multicenter cohort study,Haemophilia,2011,,https://experts.mcmaster.ca/display/publication995806,2025-07-27T15:08:23.044259
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Predictors of inhibitor development in haemophilia A previously untreated patients: the role of factor concentrate type. An individual patient data meta-analysis,Haemophilia,2011,,https://experts.mcmaster.ca/display/publication995811,2025-07-27T15:08:23.044261
Alfonso Iorio,iorioa@mcmaster.ca,conferences,A Predictive Model for the Development of High-Responding Inhibitor In Children. with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study,Blood,2010,,https://experts.mcmaster.ca/display/publication995803,2025-07-27T15:08:23.044262
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients,Blood,2010,,https://experts.mcmaster.ca/display/publication995795,2025-07-27T15:08:23.044263
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies],Blood,2010,,https://experts.mcmaster.ca/display/publication995802,2025-07-27T15:08:23.044264
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Bioequivalence of B-domain deleted and plasma derived FVIII concentrates,Haemophilia,2010,,https://experts.mcmaster.ca/display/publication995814,2025-07-27T15:08:23.044266
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Bone mineral density in hemophilia patients: a meta-analysis,Haemophilia,2010,,https://experts.mcmaster.ca/display/publication995817,2025-07-27T15:08:23.044267
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B,Haemophilia,2010,,https://experts.mcmaster.ca/display/publication995821,2025-07-27T15:08:23.044269
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Effect of plasma-derived or recombinant factor VIII on inhibitor development: a systematic review,Haemophilia,2010,,https://experts.mcmaster.ca/display/publication995823,2025-07-27T15:08:23.044270
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Predictors of success in immune tolerance induction (ITI) in haemophilia A patients with high-responding inhibitors: the Italian ITI registry,Haemophilia,2010,,https://experts.mcmaster.ca/display/publication995830,2025-07-27T15:08:23.044272
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Recombinant factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors,Haemophilia,2010,,https://experts.mcmaster.ca/display/publication995820,2025-07-27T15:08:23.044273
Alfonso Iorio,iorioa@mcmaster.ca,conferences,IDIOPATHIC VEIN THROMBOSIS: IDENTIFICATION OF POPULATIONS AT DIFFERENT RISK OF RELAPSE FOLLOWING ORAL ANTICOAGULANT TREATMENT. THE RESULTS OF THE 'EXTENDED-DACUS STUDY',Haematologica,2010,,https://experts.mcmaster.ca/display/publication1683963,2025-07-27T15:08:23.044275
Alfonso Iorio,iorioa@mcmaster.ca,conferences,PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS,Haematologica,2010,,https://experts.mcmaster.ca/display/publication1683964,2025-07-27T15:08:23.044276
Alfonso Iorio,iorioa@mcmaster.ca,conferences,IDIOPATHIC VEIN THROMBOSIS: IDENTIFICATION OF POPULATIONS AT DIFFERENT RISK OF RELAPSE FOLLOWING ORAL ANTICOAGULANT TREATMENT. THE RESULTS OF THE 'EXTENDED-DACUS STUDY',Haematologica,2010,,https://experts.mcmaster.ca/display/publication995826,2025-07-27T15:08:23.044277
Alfonso Iorio,iorioa@mcmaster.ca,conferences,PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS,Haematologica,2010,,https://experts.mcmaster.ca/display/publication995822,2025-07-27T15:08:23.044278
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Effect of plasma-derived or recombinant factor VIII on inhibitor development. A systematic review,Haemophilia,2010,,https://experts.mcmaster.ca/display/publication995833,2025-07-27T15:08:23.044280
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Impact of Thrombophilia On Arterial Ischemic Stroke or Cerebral Venous Sinus Thromboses in Children: A Systematic Review & Meta-Analysis of Observational Studies,Blood,2009,,https://experts.mcmaster.ca/display/publication995844,2025-07-27T15:08:23.044281
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.,Blood,2009,,https://experts.mcmaster.ca/display/publication995832,2025-07-27T15:08:23.044282
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature,Blood,2009,,https://experts.mcmaster.ca/display/publication995839,2025-07-27T15:08:23.044284
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Audit of the clinical use of fresh-frozen plasma in umbria: study design and results,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305094,2025-07-27T15:08:23.044285
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Bone mineral density in hemophilia patients: a meta-analysis,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305009,2025-07-27T15:08:23.044286
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Central nervous system (CNS) bleeding in patients with rare bleeding disorders (RBDS),Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305093,2025-07-27T15:08:23.044287
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Clinical prediction guide to predict thrombosis recurrence after a first unprovoked venous thromboembolism,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305013,2025-07-27T15:08:23.044289
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the two coagulation disorders,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305092,2025-07-27T15:08:23.044290
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Computer assisted VKA monitoring with point of care device by general practitioners,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305089,2025-07-27T15:08:23.044292
Alfonso Iorio,iorioa@mcmaster.ca,conferences,D-dimer to predict thrombosis recurrence after unprovoked venous thromboembolism: effect of patient- and D-dimer-related factors on recurrence prediction,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305008,2025-07-27T15:08:23.044293
Alfonso Iorio,iorioa@mcmaster.ca,conferences,D-dimer to predict thrombosis recurrence: comparison of aggregate data and individual patient data meta-analyses,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305007,2025-07-27T15:08:23.044294
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Does patient sex and prior hormonal therapy predict risk for thrombosis recurrence after a first venous thromboembolism?,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305010,2025-07-27T15:08:23.044296
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Does the clinical presentation of venous thromboembolism predict the risk for and type of thrombosis recurrence?,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305012,2025-07-27T15:08:23.044297
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Factor VIII gene (F8) mutations as a predictor of outcome in immune tolerance induction (ITI) in hemophilia A patients with high-responding inhibitors,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305090,2025-07-27T15:08:23.044298
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Intracranial haemorrhage in haemophilia A and B: an italian retrospective survey,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305091,2025-07-27T15:08:23.044299
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Multicentric evaluation of current dosing practice of recombinant fix in italy,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305087,2025-07-27T15:08:23.044301
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Plasma derived (PD) and recombinant (R) factor VIII (FVIII) concentrates induce a different rate of inhibitor development in hemophilia A patients. a systematic review of the literature,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305014,2025-07-27T15:08:23.044302
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Prospective assessment of clinical endpoints of VKA treatment in a primary care computer assisted management model,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305088,2025-07-27T15:08:23.044303
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Venous thromboembolism recurrence after a first episode of provoked venous thrombosis due to a transient risk factor. A systematic review of the literature,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3305011,2025-07-27T15:08:23.044305
Alfonso Iorio,iorioa@mcmaster.ca,conferences,International clinical trials are the best way to improve global haemophilia care? No,Haemophilia,2009,,https://experts.mcmaster.ca/display/publication995837,2025-07-27T15:08:23.044306
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature,Blood,2008,,https://experts.mcmaster.ca/display/publication995834,2025-07-27T15:08:23.044309
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Antiviral therapy for chronic hepatitis C in haemophilia patients with human immunodeficiency virus,Clinical Respiratory Journal,2008,10.1002/14651858.cd004888,https://experts.mcmaster.ca/display/publication995632,2025-07-27T15:08:23.044311
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Causes of death among Italian hemophiliacs: results from the Italian Association of Hemophilia Centers (AICE) Survey,Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995634,2025-07-27T15:08:23.044312
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"Clinical audit of fresh frozen plasma usage in Umbria, Italy",Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995627,2025-07-27T15:08:23.044313
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Critical appraisal of five international guidelines on fresh frozen plasma clinical use,Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995629,2025-07-27T15:08:23.044315
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Factor IX pharmacokinetics: differences between plasma‐derived and recombinant products and the clinical and economic implications: a meeting report,Haemophilia,2008,10.1111/j.1365-2516.2008.01762.x,https://experts.mcmaster.ca/display/publication995625,2025-07-27T15:08:23.044316
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Haemophilia A and B and other rare bleeding disorders: an Italian retrospective survey on the intracranial haemorrhagic episodes,Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995626,2025-07-27T15:08:23.044317
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Immune tolerance induction (ITI) in patients with hemophilia A and inhibitors: the Italian retrospective-prospective registry - the PROFIT study,Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995628,2025-07-27T15:08:23.044319
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger?,Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995633,2025-07-27T15:08:23.044320
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Pharmacokinetics of reformulated B-domain deleted recombinant factor VIII (BDD-rFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS),Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995631,2025-07-27T15:08:23.044322
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Replacement therapy with recombinant FIX - multicentre evaluation of current dosing practice in Italy,Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995636,2025-07-27T15:08:23.044323
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The haemophilia registry of the Italian Association of Haemophilia Centres,Haemophilia,2008,,https://experts.mcmaster.ca/display/publication995635,2025-07-27T15:08:23.044324
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Pharmacokinetics of the reformulated B-DOMAIN deleted recombinant factor VIII (BDD-RFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS),Haematologica,2007,,https://experts.mcmaster.ca/display/publication995644,2025-07-27T15:08:23.044326
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Pharmacokinetics of the reformulated B-domain deleted recombinant factor VIII concentrate using chromogenicand one-stage assays with pooled normal plasma and refacto laboratory standard,Haematologica,2007,,https://experts.mcmaster.ca/display/publication995637,2025-07-27T15:08:23.044333
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Systematic Review of Randomized Controlled Trials of Prophylactic Clotting Factor Concentrate in Hemophilia.,Blood,2005,10.1182/blood.v106.11.3114.3114,https://experts.mcmaster.ca/display/publication995640,2025-07-27T15:08:23.044334
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Accreditation standard for surveillance center for patients undergoing oral anticoagulant therapy,Rivista di Medicina di Laboratorio,2002,,https://experts.mcmaster.ca/display/publication1747348,2025-07-27T15:08:23.044336
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: A metanalysis,Thrombosis and Haemostasis,1999,,https://experts.mcmaster.ca/display/publication995829,2025-07-27T15:08:23.044337
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Plasma homocysteine measurement: Comparison of three different assay methods in plasma from vascular patients,Thrombosis and Haemostasis,1999,,https://experts.mcmaster.ca/display/publication995825,2025-07-27T15:08:23.044339
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Risk factors for venous thromboembolism in patients undergoing elective neurosurgery,Thrombosis and Haemostasis,1999,,https://experts.mcmaster.ca/display/publication995816,2025-07-27T15:08:23.044340
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Serine base exchange enzyme in commercially available porcine lyophilized platelets: Different effect of unfractionated heparin and low molecular weight heparin,Thrombosis and Haemostasis,1999,,https://experts.mcmaster.ca/display/publication995824,2025-07-27T15:08:23.044342
Alfonso Iorio,iorioa@mcmaster.ca,conferences,The role of thrombophilic states in the bleeding tendency of patients with hemophilia,Thrombosis and Haemostasis,1999,,https://experts.mcmaster.ca/display/publication995815,2025-07-27T15:08:23.044343
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Three-months compared with one-year of oral anticoagulant treatment after a first idiopathic deep vein thrombosis: The warfarin optimal duration Italian trial (WODIT),Thrombosis and Haemostasis,1999,,https://experts.mcmaster.ca/display/publication995827,2025-07-27T15:08:23.044344
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Enoxaparin plus compression stockings versus compression stockings alone in the prevention of venous thromboembolism (VTE) in neurosurgery patients: A randomised double blind venography study,Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication995881,2025-07-27T15:08:23.044346
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Plasma heparin level and coronary patency in patients with acute myocardial infarction treated with a double rt-PA bolus and randomised to two different heparin regimens,Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication995866,2025-07-27T15:08:23.044347
Alfonso Iorio,iorioa@mcmaster.ca,conferences,Withdrawal of warfarin therapy after deep vein thrombosis: A randomised study on the effects of a very low fixed dose regimen,Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication995872,2025-07-27T15:08:23.044352
Alfonso Iorio,iorioa@mcmaster.ca,conferences,EFFECTS OF DERMATAN SULFATE ON ACTIVATED PARTIAL THROMBOPLASTIN TIME DETERMINED WITH 5 DIFFERENT REAGENTS,Thrombosis and Haemostasis,1995,,https://experts.mcmaster.ca/display/publication995870,2025-07-27T15:08:23.044353
Alfonso Iorio,iorioa@mcmaster.ca,conferences,FIBRINOGENOLYSIS AND THROMBIN ACTIVATION AFTER ACCELERATED WEIGHT-ADJUSTED OR CONVENTIONAL ADMINISTRATION OF RT-PA FOR PULMONARY-EMBOLISM,Thrombosis and Haemostasis,1995,,https://experts.mcmaster.ca/display/publication995877,2025-07-27T15:08:23.044355
Alfonso Iorio,iorioa@mcmaster.ca,conferences,POSTDISCHARGE CLINICALLY OVERT THROMBOEMBOLIC EVENTS IN ORTHOPEDIC-SURGERY PATIENTS WITH NEGATIVE VENOGRAPHY,Thrombosis and Haemostasis,1995,,https://experts.mcmaster.ca/display/publication995874,2025-07-27T15:08:23.044356
Alfonso Iorio,iorioa@mcmaster.ca,conferences,THE DISPLACEMENT OF NONSPECIFICALLY BOUND UNFRACTIONATED HEPARIN FROM PLASMA-PROTEINS PRODUCES AN ANTITHROMBOTIC EFFECT,Thrombosis and Haemostasis,1995,,https://experts.mcmaster.ca/display/publication995883,2025-07-27T15:08:23.044357
Alfonso Iorio,iorioa@mcmaster.ca,conferences,EX-VIVO COMPARISON OF THE NONSPECIFIC-BINDING OF UNFRACTIONATED HEPARIN AND ENOXAPARIN TO PLASMA-PROTEINS,Thrombosis and Haemostasis,1993,,https://experts.mcmaster.ca/display/publication821713,2025-07-27T15:08:23.044359
Alfonso Iorio,iorioa@mcmaster.ca,conferences,"INHIBITION OF FLUID-PHASE AND CLOT-BOUND THROMBIN - EFFECTS OF HEPARIN, HIRUDIN AND A THROMBIN-INHIBITING DECAPEPTIDE (LU-58463)",Thrombosis and Haemostasis,1993,,https://experts.mcmaster.ca/display/publication995867,2025-07-27T15:08:23.044360
Alfonso Iorio,iorioa@mcmaster.ca,conferences,KINETICS OF PLASMA THROMBIN NEUTRALIZING ACTIVITY IN PATIENTS WITH DEEP-VEIN THROMBOSIS TREATED WITH SUBCUTANEOUS HEPARIN TWICE A DAY,Thrombosis and Haemostasis,1993,,https://experts.mcmaster.ca/display/publication995871,2025-07-27T15:08:23.044361
Alfonso Iorio,iorioa@mcmaster.ca,conferences,PLASMA HALF-LIFE OF THE ANTI-IIA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS ASSESSED WITH A SENSITIVE TEST (PTNA),Thrombosis and Haemostasis,1993,,https://experts.mcmaster.ca/display/publication821717,2025-07-27T15:08:23.044362
Alfonso Iorio,iorioa@mcmaster.ca,conferences,PLATELET INHIBITION INDUCED BY PLASMINOGEN ACTIVATORS - ROLE OF FIBRINOGEN DEGRADATION PRODUCTS,Thrombosis and Haemostasis,1993,,https://experts.mcmaster.ca/display/publication995879,2025-07-27T15:08:23.044364
Alfonso Iorio,iorioa@mcmaster.ca,conferences,SELECTIVE-INHIBITION OF ALLOGRAFT-RESPONSE BY MURINE VIRUS,Annali Sclavo. Collana monografica,1975,,https://experts.mcmaster.ca/display/publication3520895,2025-07-27T15:08:23.044365
Alfonso Iorio,iorioa@mcmaster.ca,conferences,EVIDENCE FOR VIRAL NATURE OF AN IMMUNODEPRESSIVE FACTOR (IDF) ASSOCIATED WITH VARIOUS TRANSPLANTABLE TUMORS,The FASEB Journal,1974,,https://experts.mcmaster.ca/display/publication3520896,2025-07-27T15:08:23.044366
Alfonso Iorio,iorioa@mcmaster.ca,preprints,"Attitudes and Perceptions of University Students and Postdoctoral Fellows in the Medical and Life Sciences Towards the Use of Artificial Intelligence Chatbots in the Educational Process: A Large-Scale, International Cross-Sectional Survey",,2025,10.1101/2025.06.25.25328523,https://experts.mcmaster.ca/display/publication3607070,2025-07-27T15:08:23.044368
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Policies on Artificial Intelligence Chatbots Among Academic Publishers: A Cross-Sectional Audit,,2024,10.1101/2024.06.19.24309148,https://experts.mcmaster.ca/display/publication3441879,2025-07-27T15:08:23.044369
Alfonso Iorio,iorioa@mcmaster.ca,preprints,The McMaster Health Information Research Unit: Over a Quarter-Century of Health Informatics Supporting Evidence-Based Medicine (Preprint),,2024,10.2196/preprints.58764,https://experts.mcmaster.ca/display/publication3413012,2025-07-27T15:08:23.044371
Alfonso Iorio,iorioa@mcmaster.ca,preprints,"Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Large-Scale, International Cross-Sectional Survey",,2024,10.1101/2024.02.27.24303462,https://experts.mcmaster.ca/display/publication3402622,2025-07-27T15:08:23.044372
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Researcher and Clinician Preferences for a Journal Transparency Tool: A Mixed-Methods Survey and Focus Group Study,,2024,10.1101/2024.05.28.24307345,https://experts.mcmaster.ca/display/publication3490130,2025-07-27T15:08:23.044373
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Protocol for a Cross-Sectional Survey,,2023,10.1101/2023.07.26.23293211,https://experts.mcmaster.ca/display/publication3282107,2025-07-27T15:08:23.044375
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Machine learning to increase the efficiency of a literature surveillance system: a performance evaluation,,2023,10.1101/2023.06.18.23291567,https://experts.mcmaster.ca/display/publication3267865,2025-07-27T15:08:23.044376
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Selective serotonin reuptake inhibitors for children with Autism Spectrum Disorder: a systematic review and meta-analysis,,2023,10.21203/rs.3.rs-2757603/v1,https://experts.mcmaster.ca/display/publication3437457,2025-07-27T15:08:23.044377
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Machine learning to increase the efficiency of a literature surveillance system: a performance evaluation (Preprint),,2022,10.2196/preprints.42982,https://experts.mcmaster.ca/display/publication3236693,2025-07-27T15:08:23.044379
Alfonso Iorio,iorioa@mcmaster.ca,preprints,"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study (Preprint)",,2021,10.2196/preprints.30797,https://experts.mcmaster.ca/display/publication3285816,2025-07-27T15:08:23.044380
Alfonso Iorio,iorioa@mcmaster.ca,preprints,"Machine Learning Approaches to Retrieve High-Quality, Clinically Relevant Evidence From the Biomedical Literature: Systematic Review (Preprint)",,2021,10.2196/preprints.30401,https://experts.mcmaster.ca/display/publication3401692,2025-07-27T15:08:23.044381
Alfonso Iorio,iorioa@mcmaster.ca,preprints,A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation (Preprint),,2021,10.2196/preprints.29398,https://experts.mcmaster.ca/display/publication3236696,2025-07-27T15:08:23.044383
Alfonso Iorio,iorioa@mcmaster.ca,preprints,A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study (Preprint),,,10.2196/preprints.10281,https://experts.mcmaster.ca/display/publication3461855,2025-07-27T15:08:23.044384
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Attitudes and Perceptions of Biomedical Journal Editors-in-Chief Towards the Use of Artificial Intelligence Chatbots in the Scholarly Publishing Process: A Cross-Sectional Survey,,,10.1101/2025.05.26.25328101,https://experts.mcmaster.ca/display/publication3593236,2025-07-27T15:08:23.044385
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Effects of Electronic Prescribing on Adherence to Prescribed Medications in Community Settings: A Systematic Review (Preprint),,,10.2196/preprints.73599,https://experts.mcmaster.ca/display/publication3582039,2025-07-27T15:08:23.044387
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Fine-Tuning and Benchmarking Transformer Models for Multiclass Classification of Clinical Research Articles: Modeling Study (Preprint),,,10.2196/preprints.77311,https://experts.mcmaster.ca/display/publication3587738,2025-07-27T15:08:23.044388
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Knowledge translation strategies for sharing evidence-based health information with older adults and their caregivers: Findings from a co-design study,,,10.21203/rs.3.rs-373549/v1,https://experts.mcmaster.ca/display/publication3461844,2025-07-27T15:08:23.044389
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Recommendations and Guidelines for Creating Scholarly Journals: A Scoping Review,,,10.31219/osf.io/5d72z,https://experts.mcmaster.ca/display/publication3461843,2025-07-27T15:08:23.044391
Alfonso Iorio,iorioa@mcmaster.ca,preprints,Translating Clinical Questions by Physicians Into Searchable Queries: Analytical Survey Study (Preprint),,,10.2196/preprints.16777,https://experts.mcmaster.ca/display/publication3461847,2025-07-27T15:08:23.044392
